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Mental health conditions affect various aspects of an individual’s quality of life (QOL). 
Patients with anxiety and depression have a greater risk of having a negative perception 
of QOL. The gap in practice was the lack of an assessment tool to measure QOL in 
patients with mental health disorders. The purpose of this Doctor of Nursing Practice 
project was to develop a clinical practice guideline (CPG) recommending the best 
evidence-based measurement tool for QOL in patients with anxiety and/or depression. 
The question that guided the CPG was: How should QOL be measured in patients with 
anxiety and/or depression in the outpatient setting? The CPG could help clinicians ask 
precise questions regarding the impact of anxiety and/or depression on patients’ QOL and 
adjust the treatment plan to improve patient outcomes. The literature used to support the 
CPG was graded, synthesized into recommendations, and evaluated by an expert panel 
using the Appraisal of Guidelines Research and Evaluation (AGREE) II tool. The World 
Health Organization Quality of Life Instrument-Short Form (WHOQOL-BREF) 
questionnaire was recommended in the CPG as a reliable measurement tool to evaluate 
QOL in patients with anxiety and/or depression. Peplau's interpersonal relations theory 
was applied to emphasize the proper way for clinicians to interact with patients when 
administering the WHOQOL-BREF questionnaire. The anticipated outcome of adoption 
of the CPG is the efficient use of resources to improve patients’ QOL. The CPG is 
intended to assist clinicians to evaluate and understand QOL perceptions to achieve the 
social change of enhancing patient outcomes by improving treatment plans. 
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Section 1: Nature of the Project 
Introduction 
In 2017, there were approximately 46.6 million adults aged 18 or older in the 
United States with mental illness, this number signified 18.9% of all U.S. adults 
(National Institute of Mental Health, 2019).  According to Huo, Guo, Shenkman and 
Muller (2018), as many as 25% of adults in the United States has some form of mental 
health problem. Patients diagnosed with mental health disorders are known to have an 
increased rate of chronic diseases including but not limited to cardiovascular diseases, 
diabetes, obesity, asthma, epilepsy, and cancer (Huo et al., 2018). Mental health disorders 
affect various aspects of the individual’s quality of life (QOL), such as their personal and 
social relationships, employment, schooling, and physical abilities. It has been shown that 
patients with other medical illnesses in addition to mental health disorders have 
considerably greater impairment of their QOL (Huo et al., 2018).  
Specifically, depression is a prevalent cause of disability worldwide (Choo, 
Chew, Ho, & Ho, 2019). The World Health Organization (WHO) has projected that by 
the year 2020, depression will be deemed the third leading cause of disability globally 
(Sivertsen, Bjorklof, Engedal, Selbaek, & Helvik, 2015). Compared with other mental 
disorders, depressed patients have reported lower QOL (Choo et al., 2019). Prior studies 
observed that domestic life, work, and interpersonal activities were believed to be the 
most altered functional domains in depression (Choo et al., 2019). People with depression 
are more susceptible to having adverse outcomes such as low education level, marital 
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disturbances, erratic employment, risk of developing secondary disorders, and premature 
mortality because of suicide (Choo et al., 2019). 
Similarly, anxiety disorders represent the most predominant classification of 
mental health disorders (Muntingh, van der Feltz-Cornelis, van Marwijk, Spinhoven, & 
van Balkom, 2016). Anxiety disorders can also have a negative effect on a person’s QOL 
and are related to significant healthcare and productivity financial burden (Muntingh et 
al., 2016). Anxiety and depression are among the most common mental health problems 
across various ages of the lifespan (Hohls, König, Quirke & Hajek, 2019). Both disorders 
have been linked to a substantial economic burden and adverse consequences including 
increased risk for physical comorbidities (Hohls et al., 2019). For reasons previously 
stated, it is vital to address these chronic mental health conditions to not only reduce 
healthcare cost but to improve overall patient care and outcomes.  
Problem Statement 
QOL is defined as a person’s perception of their personal situation with regards to 
their own physical, social, mental, and spiritual dimensions (Pinto, Fumincelli, Mazzoc, 
Caldeira and Martins, 2017). QOL also refers to an individual’s well-being, satisfaction 
in life, physical health, perceptions of social relationships, economic status, and 
operational in activities of daily living and work. (Hofmann, Curtiss, Carpenter & Kind, 
2017). This is normally evaluated through the subjective views of the person’s life 
situations, perceptions of their mental and physical health, social and family 
relationships, and functional ability at home and work (Hofmann et al., 2017).  
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Effective treatments of mental health disorders such as depression can result in a 
decline in depressive symptoms, improvement of psychosocial functioning, and increased 
QOL (Hofmann et al., 2017). Nevertheless, the treatment effects on QOL have not 
obtained as much attention as clinical measures of mental health disorders such as 
depression or anxiety (Hofmann et al., 2017). It is likely due to regulatory agencies not 
putting much value on QOL measures because they are not considered a primary 
outcome measure during clinical trials (Hofmann et al., 2017). However, QOL measures 
can affect treatments of mental health disorders by helping clinicians to carefully plan 
and adjust treatments accordingly.  
Connell, O'Cathain and Brazier (2014) mentioned that there have been changes in 
the way mental health services are provided, changing from emphasis on treatment and 
decreasing symptoms to a holistic approach taking into consideration of well-being, 
recovery, social functioning, and QOL. For more people receiving mental health services 
to recover and have a good QOL, there is a need for appropriate outcome measures to be 
implemented (Connell et al., 2014). However, limited measures have been standardized 
and regularly gathered across mental health services (Connell et al., 2014). QOL is 
affected by the individual’s beliefs, values, well-being, and life experiences. Because 
patients with mental health disorders have a greater risk of having a negative perception 
of QOL, it is essential to identify the best approach to measure QOL in patients with 
mental health disorders, specifically anxiety and/or depression. Clinicians can adopt this 
approach to measure QOL in patients with anxiety and/or depression to better plan and 




The purpose of this Doctor of Nursing Practice (DNP) project was to develop a 
clinical practice guideline (CPG) that provides recommendation on how to measure QOL 
in patients with anxiety and/or depression. After review of the literature, I developed a 
CPG identifying the most appropriate way to measure QOL and recommended it for use 
in clinical practice, specifically with patients diagnosed with anxiety and/or depression in 
the outpatient setting. Clinicians working with patients suffering from anxiety and/or 
depression can use this CPG to evaluate a patient’s QOL. Currently, there is no gold 
standard for measuring QOL, especially in mental health patients (Katschnig, 2006). 
Therefore, it was necessary to develop a CPG that can guide clinicians on how to 
evaluate patients’ perceptions of QOL as it relates to their disease process to 
appropriately manage their treatments. Upon further review of the literature, the most 
recent sources of evidence that discussed a gold standard for measuring QOL in mental 
health patients could not be located; hence, I used of the article by Katschnig (2006). 
In developing the CPG, Peplau’s interpersonal relationship middle-range 
descriptive theory was used to emphasize the significance of interpersonal relationships. 
Peplau’s work on interpersonal relations has had a significant impact on the development 
of contemporary nursing and psychiatric nursing (Adams, 2017). Before QOL can be 
properly evaluated, it is imperative that interpersonal relations are established to 
effectively understand patients’ perceptions while being cognizant of the evaluator’s own 
behavior. Peplau’s theory was used to guide clinicians on the best approach to interact 
with patients when evaluating their QOL.  
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Nature of the Doctoral Project 
The doctoral project necessitated an extensive and vigorous literature review to 
identify the best tool to measure QOL in patients with anxiety and/or depression. I 
analyzed and synthesized the evidence retrieved from the literature review for relevance, 
high quality, reliability, and validity. Each item of evidence was translated and 
scrutinized to identify the best method to measure QOL in patients with anxiety and/or 
depression. Based on the findings from the literature review process, I developed a CPG 
recommending the best approach to measure QOL in patients with anxiety and/or 
depression. After a robust literature review, I identified the World Health Organization 
Quality of Life Instrument-Short Form (WHOQOL-BREF) questionnaire as the best tool 
for clinicians to use to measure QOL in patients with anxiety and/or depression seeking 
care in the outpatient setting. Clinicians working in outpatient setting (i.e., primary care) 
can use the guideline as a framework to measure QOL in the target population by asking 
specific questions outlined in each domain of the WHOQOL-BREF questionnaire.  
Significance 
Because mental health illnesses account for many disabilities in the United States 
and worldwide, it was imperative to address this issue using an evidence-based CPG for 
proper management. Developing a CPG that identifies the best QOL measurement tool to 
utilize in clinical practice was necessary. The guideline would show the best way to use 
the identified tool to evaluate QOL in a specified population for a social impact in 
healthcare. A CPG on the QOL measurement tool was necessary to help clinicians 
evaluate and understand QOL perceptions among individuals with anxiety and/or 
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depression disorders. This CPG could enhance patient outcomes and impact treatment 
plans to decrease disability rates nationally and globally.  
Prasad, Angothu, Mathews and Chaturvedi (2016) mentioned that depression is 
one of the most common mental health disorders and is estimated to be the fourth leading 
cause of disability worldwide. Depression is estimated to become the second leading 
cause of disability worldwide by 2020 according to the WHO (World Federation for 
Mental Health, 2012). It is therefore important to develop a CPG to address such 
disorders. Effective use of this CPG in the outpatient setting could promote its adoption 
in other clinical areas to enhance quality of care and reduce healthcare costs related to 
anxiety and/or depression disorders. This project can promote positive social change 
according to Walden University’s mission by improving mental health and encouraging 
people, organizations, and society to adopt a new best practice for a positive future. 
Summary 
Pinto et al. (2017) explained QOL as an individual’s perception of their personal 
situation regarding their own physical, social, mental, and spiritual dimensions. Anxiety 
and/or depression can have a negative impact on the QOL of individuals. Therefore, 
incorporating this CPG into clinical practice can result in changes in care delivery as well 
as making this CPG the gold standard for measuring QOL in patients with anxiety and/or 
depression, especially because there is currently none available to clinicians. Effective 
use of this CPG can enhance clinicians’ overall understanding about the impact of 
anxiety and/or depression on patients’ QOL. Knowledge regarding this impact can help 
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clinicians to either amend or enhance treatment plans to meet patient needs and improve 
their overall QOL.  
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Section 2: Background and Context 
Introduction 
In the CPG development, it was important to add concepts, models, and theories 
to support the information presented in the guideline. Doing so adds quality and strength 
to the information suggested in the CPG and promotes its use in practice. This section 
focuses on the theory that clinicians can use when interacting with patients. The theory 
can be applied when clinicians are asking questions and implementing the interventions 
outlined in the CPG. The theory also explains specific behaviors that must be illustrated 
when clinicians interact with patients. In this section, I also provide a brief overview 
regarding the background information on the context and the theory applied in the CPG. 
Additionally, the relevance of the CPG to nursing practice demonstrated in this section, 
highlighting the necessity for the CPG development.  
Theory 
I used Peplau’s theory to guide the development of this CPG. Peplau's theory 
focused on psychodynamic nursing to help nurses understand their own and others’ 
behaviors while applying principles of human relations to the problems that arise at 
various experience levels (Adams, 2017). Peplau defined nursing “as an interpersonal, 
therapeutic process that takes place when professionals, specifically educated to be 
nurses, engage in therapeutic relationships with people who are in need of health 
services” (Hagerty, Samuels, Norcini-Pala & Gigliotti, 2017, p. 162-163). Forming an 
effective interpersonal relationship with patients is vital to positive health outcomes. 
According to Peplau’s theory, the nurse-patient relationship must undergo three various 
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phases for it to be successful. These phases are (a) orientation, (b) working, and (c) 
termination (Hagerty et al., 2017).  
Though there are three phases in Peplau’s theory, I used only the orientation and 
working phases in this CPG. In the orientation phase of the theory, the nurse meets and 
greets the patient who is seeking assistance with a perceived health problem (Adams, 
2017). This phase permits nurses to meet patients to attain valuable information about 
them as individuals (Hagerty et al., 2017). In the orientation phase, nurses must adopt the 
role of a stranger but show respect and courtesy when interacting with the patient 
(Hagerty et al., 2017). The working phase requires nurses to spend significant amount of 
time interacting with the patient, conducting assessments to use in the patient education 
and interdisciplinary meetings on patients’ care plans (Hagerty et al., 2017). During the 
working phase, the roles of nurses are more recognizable to patients and they begin to 
acknowledge nurses as health educators, resource personnel, counselors, and care 
providers (Hagerty et al., 2017).  
This CPG recommended that clinicians apply the two phases of Peplau’s theory as 
guidance when asking patients questions outlined in the WHOQOL-BREF questionnaire. 
For instance, in the orientation phase of Peplau’s theory, nurses are urged to show respect 
and courtesy when interacting with patients (Hagerty et al., 2017). Likewise, when 
clinicians are asking questions pertaining to the various domains on the WHOQOL-
BREF questionnaire, they are advised to do so in a respectful and courteous manner to 
acquire helpful information. The working phase of Peplau’s theory is where time is spent 
to conduct assessments to influence patients’ care (Hagerty et al., 2017). Clinicians are 
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encouraged to apply the working phase of Peplau’s theory when conducting QOL 
assessment of patients with anxiety and/or depression using the WHOQOL-BREF 
questionnaire. Because the working phase demands extensive time to perform various 
tasks , the CPG recommends clinicians to allocate sufficient time with patients when 
eliciting the WHOQOL-BREF questionnaire to avoid rushing the assessment phase 
because this can lead to skewed or unreliable responses. Employing the working phase of 
Peplau’s theory can provide an opportunity to strengthen the clinician-patient 
interpersonal relationship as well as obtain valuable responses to better understand the 
impact of depression and/or anxiety on patients’ QOL.  
Peplau’s theory contributed substantially to the formation of psychiatric/mental 
health nursing as a clinical specialty (Adams, 2017). Psychiatric nursing has had an 
important role the field of nursing and has served as the model for the whole 
advancement of clinical nursing in the United States (Adams, 2017). Because the CPG 
focused on psychiatric nursing, Peplau’s theory was quite applicable to help clinicians 
understand their own as well as their patients’ behavior and apply principles of human 
relations for a successful clinician-patient relationship.  
Clinicians must incorporate strong interpersonal relations skills when interacting 
with patients with depression and/or anxiety because ineffective coping mechanisms by 
patients tend to result in negative feelings of self. However, with therapeutic 
interpersonal skills, relationships between health care professionals and patients lead to 
improved patient satisfaction, treatment adherence, improved QOL, and reduced levels of 
anxiety and depression (Kornhaber, Walsh, Duff & Walker, 2016). Using interpersonal 
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relations skills as illustrated in the orientation and working phases of Peplau’s theory can 
help clinicians develop effective approaches for asking the questions on the WHOQOL-
BREF questionnaires, which may yield valuable responses to influence care.  
Peplau’s theory was clearly demonstrated in a study conducted by Evans, 
Deutsch, Drake, and Bullock (2017), which examined the nurse-patient relationship 
settings through telephone encounters with underserved women at high risk for 
depression residing in rural settings. From this study, researchers discovered that the 
phases of Peplau’s theory were evident in their interactions and offered a robust platform 
from which to validate and develop nursing interventions designed to improve mental 
health (Evans et al., 2017).  
For instance, during the orientation phase of Peplau’s theory in the study, the 
nurse’s initial contact with the patient consisted of the nurse asking about the woman’s 
smoking behaviors, and the nurse was able to align her own goals with that of the patients 
(Evans et al., 2017). Additionally, the nurse evaluated the patients’ risks, resources, 
challenges, and the related factors that could disturb the interaction (Evans et al., 2017). 
The participants responded positively, which reflected their wish to participate in the 
study as well as to share details about their lives (Evans et al., 2017). Likewise, in the 
CPG, if clinicians apply the specified domains of Peplau’s theory such as the orientation 
and the working phases, they will be able to seamlessly apply principles of human 
relations to strengthen the clinician-patient relationship. Doing so can allow clinicians to 
effectively deliver the WHOQOL-BREF assessment and gain valuable responses from 
patients to better understand their QOL and modify treatment plans accordingly.  
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Relevance to Nursing Practice 
The aim of the CPG was to provide a method to translate evidence into nursing 
practice to improve patient outcomes. Because anxiety and depression have such a 
significant impact on the lives of affected individuals, it is imperative to address this 
public health problem to increase patients’ QOL and decrease the financial healthcare 
burden. Nursing professionals caring for individuals with anxiety and/or depression can 
use this CPG as a method to evaluate the impact of patients’ conditions on their QOL. 
Based on the information gathered from the CPG, nurses can collaborate with providers 
to either initiate or amend specific treatments to address patients’ needs.  
Advanced practice nurses can use this CPG to assess the targeted populations’ 
QOL to generate effective treatments to meet patients’ needs. For instance, if a nurse 
practitioner (NP) use this CPG to assess that anxiety or depression has negatively 
affected a patient’s social relationships, the NP can refer the patient to the Anxiety and 
Depression Association of America website to search for a support group near the patient, 
in addition to prescribing either an antidepressant or cognitive behavioral therapy  to 
improve the patient’s QOL. However, if the NP does not specifically inquire about the 
patient’s social relationships based on the recommendations of this CPG, the nurse may 
not know the impact of the patient’s anxiety or depression on the patient’s social life in 
order to provide additional resources to enhance the patient’s mental health.  
Local Background and Context 
To inquire of patients, a series of questionnaires focusing on each domain of the 
WHOQOL-BREF can be used to gather information about how anxiety and/or depression 
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have affected the patient’s QOL, which will aid clinicians in making effective clinical 
decisions. For instance, in the WHOQOL-BREF domain on physical health, questions 
pertaining to the following areas of the patient’s physical health will be asked: activities 
of daily living, dependence on medicinal substances and medical aids, energy and 
fatigue, mobility, pain and discomfort, sleep and rest, and work capacity (WHO, 1996). 
In the psychosocial domain, questions regarding the following are asked: bodily image 
and appearance, negative feelings, positive feelings, self-esteem, 
spirituality/religion/personal beliefs, thinking, learning, memory, and concentration 
(WHO, 1996).  
Questions pertaining to social relationships focus on areas such as personal 
relationships, social support, and sexual activity (WHO, 1996). Lastly, questions centered 
on the patient’s environment are concentrated on financial resources, freedom, physical 
safety and security, health and social care such as accessibility and quality, home 
environment, opportunities for acquiring new information and skills, participation in and 
opportunities for recreation/leisure activities, physical environment 
(pollution/noise/traffic/climate), and transport (WHO, 1996). The guideline was intended 
to equip healthcare providers with accurate evidence and knowledge required to make 
informed clinical decisions and deliver safe, effective care to patients suffering from 
anxiety and/or depression. Each piece of evidence used to guide the development of this 
CPG was evaluated based on the Appraisal of Guidelines Research and Evaluation 
(AGREE) II criteria checklist to add quality and strength.  
14 
 
In a local context, there was a gap in practice observed in a primary care setting of 
a community medical center that treated patients with anxiety and/or depression. The 
standard practice of this local organization was for nurses to conduct monthly phone calls 
to patients with mental health disorders such as depression and/or anxiety and administer 
the Generalized Anxiety Disorder seven-item (GAD-7) and Patient Health Questionnaire 
nine depression scale (PHQ-9) assessment to evaluate treatment response in relation to 
antidepressants. The gap in practice was that QOL was not measured, and as a result, 
clinicians often encountered cases in which patients would have low scores on their 
GAD-7 and/or PHQ-9 but verbalized disturbances in various aspects of their life affecting 
their QOL. This gap was the reason for the development of the CPG: to help clinicians 
measure QOL and understand the impact of depression and/or anxiety on patients’ QOL 
to enhance or change treatment plans. 
Role of the Doctor of Nursing Practice Student 
As a DNP student, it was imperative to be able to translate the findings of 
literature into clinical practice to improve patient outcomes. In developing the CPG to 
measure QOL of patients battling anxiety and/or depression in the outpatient setting, a 
series of steps were followed to reach success. First, it was important to ensure that there 
was a need for development of this CPG. Based on evidence, there was not a gold 
standard for measuring QOL in mental health patients (Katschnig, 2006). Therefore, the 
role of the DNP student was to create a CPG recommending the best way to measure 




Since the CPG focused on patients with anxiety and/or depression, future 
developments of CPG can target other common mental health disorders such as 
schizophrenia, bipolar disorder, post-traumatic stress disorder or substance use disorders 
seen in the outpatient setting. Due to lack of adequate assessment of QOL of mental 
health patients, it was prudent to address this gap to ensure clinicians treating patients 
with anxiety and/or depression have a reliable resource to utilize as guidance in their 
clinical decision making.  
Second, to enhance usability and applicability in practice, evidence used to 
support the CPG was analyzed for accuracy, current and of highest level. Each piece of 
evidence used in the CPG was evaluated for quality and strength. For instance, a 
literature appraisal tool such as Grading of Recommendations, Assessment, Development 
and Evaluations (GRADE) methodology was used to appraise each article.  
Last, to ensure a high-quality CPG was developed, the AGREE II tool checklist 
was used as a guide in the guideline development to ensure transparency and 
completeness of the CPG. The AGREE II checklist has a structure of six quality areas 
and its 23 key items that provides a systematic and reasonable method for reporting 
critical information (AGREE, n.d.). The AGREE II criteria checklist is reliable and valid, 
therefore using this tool as a framework and guidance in developing this CPG will add 




Role of the Project Team 
In completion of this doctoral project, I worked with individuals from various 
healthcare backgrounds who served as my project team. Walden University assigned 
faculty members which included one committee chair and a committee member who 
served as mentors and reviewers of my project. Additionally, four external experts (one 
Internal Medicine Physician, a Primary Care Clinical Psychologist, a Doctor of Public 
Health who oversees social workers and programs for the aging adults with disabilities, 
with larger population suffering from anxiety and/or depression, and a DNP who is an 
educator as well as a floor nurse) with experience in anxiety and/or depression were 
considered to assess the developed guideline for relevance using the AGREE II checklist.  
The team members had opportunities to share their knowledge and contextual 
insight relative to the doctoral project. The team members received information regarding 
the project purpose, goals as well as the timeline to review and provide feedback. Prior to 
the final approval of the project, my project team had several opportunities to review the 
information and evidence presented in the CPG and offered substantial feedback. 
Revisions were made based on the feedback received from the project team. My project 
team were also informed on the status of the project when submissions were made to the 
Walden University’s doctoral research site.  
Summary 
The development of a CPG starts with first identifying reasons for why the 
guideline is needed to address a gap in practice. Identifying a specific theory to guide the 
development of the guideline adds quality and promotes the likelihood of its application 
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in clinical practice. The guideline has relevance to nursing practice since it offered 
recommendations for nursing profession as well as other discipline to use to enhance 
patient outcomes. It is vital to apply quality evidence when developing a CPG to enhance 
usability and applicability in practice. The incorporation of a team approach in 
developing this guideline added rigor which can promote clinical application to enhance 
outcomes in patients suffering from anxiety and/or depression.  
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Section 3: Collection and Analysis of Evidence 
Introduction 
High-quality, evidence-informed CPG provide a way to bridge the gap between 
policy, best practice, local contexts, and the choices of patients (Kredo et al., 2016). For 
decades, clinical guidelines have been supported as vital components of quality medical 
practice (Kredo et al., 2016). The Institute of Medicine (IOM) defined clinical guidelines 
as statements that consist of recommendations aimed to enhance patient care that are 
informed by systematic review of research as well as assessment of both the benefits and 
risks of alternative care (Kredo et al., 2016). The IOM statements regarding CPG align 
with the objectives of the CPG in this project. The purpose of the CPG was to help 
clinicians make informed clinical decisions regarding the proper care of patients with 
anxiety and/or depression to enhance patient care using evidence-based 
recommendations. To accomplish this, the strength of the evidence supporting the 
recommendations of the CPG underwent critical appraisal to ensure relevance and 
transparency.  
Practice-Focused Question 
The question used to guide the development of the CPG was:  
PFQ: How should QOL be measured in patients with anxiety and/or depression in 
the outpatient setting?  
The population was patients diagnosed with anxiety and/or depression who sought care in 
the outpatient setting, such as primary care. The intervention was a development of a 
CPG to assist clinicians in asking specific questions pertinent to the mental health 
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disorder (i.e., anxiety and/or depression) and its impact on various domains (physical 
health, social relationships, psychosocial situation, and environment) of patients’ QOL. 
The expected outcome was the promotion of efficient use of resources such as the CPG to 
improve outcomes and QOL. The aim of the DNP project was to develop a CPG 
recommending a QOL measurement tool to evaluate QOL of patients with anxiety and/or 
depression in the outpatient setting. The recommendations made in the guideline are 
intended to enhance patient care that are influenced by systematic review of evidence 
translated into practice to improve outcomes. 
According to Kilbourne et al. (2018) “while adequate structure measures create 
the necessary infrastructure for reporting on processes and outcomes and conducting 
improvement activities, they do not provide sufficient detail as to whether quality 
services are actually being delivered as intended nor if the outcomes obtained are 
acceptable” (p. 31). Preferably, process measures can fill this gap by assessing whether 
evidence‐based practices are in fact being employed to yield the necessary outcome 
(Kilbourne et al., 2018). These measures usually entail operationalizing clinical 
guidelines into explicitly well-defined denominators and numerators and applying 
information that can be dependably acquired from credible sources (Kilbourne et al., 
2018). Application of a CPG recommending the best way to measure QOL such as 
focusing on what, why, who and how to measure QOL in the target population can help 
clinicians make informed decisions regarding treatment plans to enhance outcomes. 
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Sources of Evidence 
There has been an increasing need for economic evaluation of mental health 
services requiring healthcare professionals to assess how a specific intervention or 
outcome measure impacts various domains of QOL important to mental health patients 
(Connell et al., 2014). Therefore, the development of a CPG on the best way to measure 
QOL can help clinicians to evaluate QOL perceptions in patients with anxiety and/or 
depression. The CPG can be recommended as a standardized outcome measure of QOL 
in patients with anxiety and/or depression. The sources of evidence used to support the 
CPG were graded, synthesized, and structurally evaluated for usability and applicability 
in practice. 
To obtain data and resources required to complete this DNP project, Walden 
University’s online library served as a platform to access various scholarly databases. 
Through the Walden online library, I conducted a computerized search of the MEDLINE, 
PubMed, and CINAHL databases to identify the most appropriate peer review literatures. 
Additionally, I conducted a review of journals, research articles, books and prior 
dissertations or theses that discussed the research question. 
I performed an advanced search using keywords such as quality of life, mental 
health disorders, psychiatric disorders, measuring quality of life, quality of life 
measurement tools, perception of quality of life, depression, and anxiety. I used Boolean 
phrase words such as AND OR to narrow the search. Additionally, each article relevant 
to the research question was appraised, graded, and rated based on the level of evidence. 
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The goal was to select research articles with the highest level of evidence to add quality 
to the CPG. Each selected article was graded using the GRADE methodology. 
I completed literature searches using MEDLINE, PubMed and CINAHL with the 
most recent search. Articles were included for review if they met the following criteria: 
(a) published not prior to 2006, (b) related to anxiety and/or depression, (c) related to 
QOL, (d) discussed QOL measurement tools, and (e) published in English. Articles were 
excluded for review if they offered subjective data (such as opinions) and were published 
in a language other than English. The following were the keyword combinations 
performed with each of the databases: (a) quality of life measurement tools AND mental 
health disorders OR mental health illness OR psychiatric disorders, (b) measuring 
quality of life AND mental health or mental illness or mental disorders AND depression 
and anxiety, and (c) WHOQOL-BREF AND mental disorders AND primary care or 
primary health care or primary healthcare. 
The intended population was adult patients, all genders, ages 18 years and older, 
seeking care in the outpatient setting. Inclusive criteria included patients diagnosed with 
either anxiety and/or depression or both and taking either an antidepressant or prescribed 
psychotherapy as first line treatments. The severity of patients’ condition must have been 
mild to severe (such as GAD7 and/or PHQ9 scores greater than four) and able to be cared 
for in an outpatient setting such as primary care. Patients with other medical conditions in 
addition to their diagnoses of anxiety, depression, or both who were competent to make 
decisions for their own healthcare were part of the inclusion criteria. 
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Analysis and Synthesis 
The aim for the DNP project was to develop a CPG recommending the best way 
to measure QOL in patients diagnosed with anxiety and/or depression for application in 
practice. I conducted a systematic review of the literature to examine various mental 
health QOL measurement tools used previously for their relevance in clinical practice. 
From this analysis of the literature, I developed a CPG recommending the best 
measurement tool to utilize in assessing QOL in patients with anxiety and/or depression.  
I critically appraised and rated each piece of evidence selected from the literature 
search using the GRADE method. GRADE methodology applies a cohesive and 
organized approach to determine the strength and direction of recommendations (Cabrera 
& Pardo, 2019). GRADE is presently deemed as the best approach to create valid and 
transparent recommendations due to its rigorous appraisal of (a) bias in the available 
evidence, (b) the extent and solidity of the effects, (c) the presence of baffling factors, 
and (d) discrepancies or other quality issues (Cabrera & Pardo, 2019). The GRADE 
system helps to evaluate and rate the quality of a body of evidence as high, moderate, 
low, or very low, and then categorizes the strength of recommendations as either strong 
or weak (Kong et al., 2015). Rating each piece of evidence using the GRADE system 
helped me to organize the quality of evidence at one of four levels (high, moderate, low, 
and very low) based on five downgrade factors including limitations, inconsistency, 
indirectness, imprecision, and publication bias (Kong et al., 2015). 
Using the GRADE system, evidence graded as ‘‘High’’ meant there was strong 
confidence that the genuine result lies closely to that of the projected outcome (Kong et 
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al., 2015). Evidence that rated as ‘‘Moderate’’ implied that there was moderate 
confidence in the projected outcome and the actual outcome is possibly close to the 
estimated effect, but there was a likelihood that it was considerably different (Kong et al., 
2015). Evidence rated as ‘‘Low’’ indicated that there was limited confidence in the 
estimated effect and that the true outcome might be significantly different from the 
estimated effect (Kong et al., 2015). Last, evidence rated as ‘‘Very low’’ suggested that 
there was very little confidence in the predicted outcome and that the real outcome 
possibly would be noticeably different from the predicted outcome (Kong et al., 2015). 
I used the GRADE methodology to rate each piece of evidence and assigned the 
level of strength for each. Once each piece of evidence was graded, I synthesized it into 
an evidence table for the purpose of managing the evidence (see Appendix A). From 
there, I developed the guideline. Once the recommendations were written with the 
supporting evidence, they were reviewed by an expert panel who used the AGREE II 
checklist to evaluate the recommendations.  
The AGREE II is a valuable tool that provides a framework for DNP to utilize as 
a guide for developing CPGs. The AGREE II was published in 2003 by a group of 
guideline developers to provide framework on evaluating the quality of guidelines 
(AGREE, 2017). I chose this tool to guide the development of this CPG. Once the CPG 
was developed, the AGREE II was used to assess the quality of the guideline. The 
AGREE II is not only valid but is a reliable tool comprising 23 key items that are 
arranged in six domains (AGREE, 2017). These six domains consist of scope and 
purpose (Domain 1); stakeholder involvement (Domain 2); rigor of development 
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(Domain 3); clarity of presentation (Domain 4); applicability (Domain 5); and editorial 
independence (Domain 6; AGREE, 2017).  
The steps involved in developing the CPG consisted of first evaluating and 
grading each piece of literature. After each piece of literature was graded, I developed the 
CPG focusing on six areas: (a) the scope and purpose section (which conveyed the 
guideline objectives, the clinical question, and the patient population to whom the 
guideline was meant to apply); (b) stakeholder involvement (which depicted the views of 
intended users); (c) rigor of development (which described the approach used to gather 
and synthesize evidence); (d) clarity of presentation (which dealt with format, structure, 
and language of the guideline); (e) applicability (which explained facilitators and barriers 
of implementation and cost of implementation); and (f) editorial dependence (which 
defined the development of recommendations not being overly biased with opposing 
interests).  
The written recommendations were reviewed and graded by a local expert panel 
who used the AGREE II instrument to validate its contents. After the expert panel scored 
the guideline based on the AGREE II instrument, I revised the guideline based on the 
feedback received from them. I disseminated the revised guideline to the same local 
experts to validate content and appropriateness using the AGREE II instrument until a 
higher score was attained without further revisions. After the development of the CPG, 
the expert panel reviewed the content, methodology, and evidence used to support the 
CPG using the AGREE II checklist. 
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Because the DNP project was to develop a CPG, there were no human study 
participants in the guideline development. As part of an ethical consideration, I obtained 
Institutional Review Board (IRB) approval prior to the development of the CPG 
(approval # 04-24-20-0980598). Prior to receipt of the IRB approval, I completed a 
specified form that was accepted by the IRB before I developed the guideline. This 
specified form consisted of information regarding the DNP project details, method of 
data collection, partner roles, and partner organization. A local primary care organization 
was selected as the partner site that can use the recommendations made in the guideline. 
Summary 
Developing a CPG that enhances care delivery and patient outcomes must be 
strategically formulated with good context based on the highest level of evidence to 
support it. To ensure the CPG was supported with the highest level of evidence, each 
piece of literature was retrieved from a scholarly database and critically appraised using 
programs such as the GRADE methodology to ensure relevance, reliability, and validity. 
Subsequently, the final CPG underwent review using the AGREE II instrument to 
evaluate whether it met the criteria outlined under each domain of the AGREE II 
checklist to ensure completeness and transparency. After appraising the CPG using the 
AGREE II, revisions were made accordingly. 
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Section 4: Findings and Recommendations 
Introduction 
Anxiety and depression have a significant impact on patients’ QOL, contributing 
to higher morbidity rates. In clinical practice, guidelines are formulated to offer clinicians 
the evidence and knowledge required to provide efficient, high-quality, and safe care to 
populations with certain clinical conditions. This section addresses the evidence used to 
support the recommendations of the guideline focusing on the strengths and limitations of 
each piece of literature. It also provides an overall discussion on how the guideline was 
developed using the GRADE methodology to analyze the evidence supporting the 
recommendations and the AGREE II instrument used to evaluate the guideline once it 
was developed. In addition, this section includes an in-depth discussion of the 
WHOQOL-BREF questionnaire as the recommended tool to measure QOL in individuals 
with anxiety and/or depression.  
In this DNP project I aimed to answer the following practice focused question:  
PFQ: How should QOL be measured in patients with anxiety and/or depression in 
the outpatient setting?  
The purpose of the CPG was to help clinicians measure QOL in patients suffering from 
anxiety and/or depression disorders to make informed decisions regarding their care and 
enhance outcomes using evidence-based recommendations. The CPG can offer guidance 
on how to evaluate patients’ perceptions of QOL based on various domains such as 
physical health, social relationships, psychological health, and environment in order to 
make necessary adjustments in their care to improve outcomes as well as their QOL.  
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Findings and Implications 
The gap in practice was that there was no guideline focused on a standardized tool 
to measure QOL for individuals with anxiety and/or depression. Therefore, I conducted a 
literature review to develop a guideline identifying the best tool to measure QOL in 
patients diagnosed with anxiety and/or depression. To create the CPG, I reviewed and 
analyzed various literature for relevance to the health question.  
Upon review of the literature, I determined there was no standardized QOL 
measurement tool for clinicians to use to assess QOL in patients with anxiety and/or 
depression. Current assessment of the impact of anxiety and/or depression on the 
patients’ health is based on the evaluation of PHQ-9 and 7-item GAD-7. These two 
assessments tools are among the best validated and most frequently used depression and 
anxiety measures, respectively (Kroenke et al., 2016). They have been applied in 
hundreds of research studies, integrated into various CPGs, and implemented by a range 
of medical and mental health care practice settings (Kroenke et al., 2016). Despite the 
validity of the PHQ9 and GAD7 assessment tool, they do not directly evaluate domains 
of QOL as illustrated on the WHOQOL-BREF questionnaire. The use of the PHQ9 and 
GAD7 in patients with anxiety and/or depression in the outpatient setting would continue 
to remain as options for assessing the impact of the disease on the individual’s health. 
However, to obtain detailed understanding on patients’ QOL, the PHQ9 and GAD7 may 
not offer clinicians adequate insights on patients’ QOL due to their specificity on 
measuring depression and anxiety.  
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Evaluating the quality of evidence is a relatively new practice that is aimed at 
determining the credibility and trustworthiness of the evidence across studies as it relates 
to a research question (Movsisyan, Dennis, Rehfuess, Grant & Montgomery, 2018). The 
body of evidence supporting the recommendations in the CPG were assessed for 
strengths and limitations. Kilbourne et al. (2018) presented a framework that supports 
quality measurement as a tool for enhancing quality of mental health care. Kilbourne et 
al. explained key barriers to this effort such as absence of standardized information 
technology-based data sources, inadequate scientific evidence for mental health quality 
measures, absence of provider training and support, as well as cultural barriers to 
integrate mental health care in general health situations. Kilbourne et al. also highlighted 
several improvements that are in progress globally to relieve these barriers.  
Slade et al. (2006) conducted a randomized control study to assess the efficacy of 
standardized outcome assessment in 160 adult mental health patients and paired staff. 
The intervention group (n = 101) completed a monthly postal questionnaire to evaluate 
their needs, QOL, severity of their mental health problems and therapeutic alliance and 
received three monthly feedbacks. The control group (n = 59) received usual treatment 
(Slade et al., 2006).  
Results showed that intervention failed to enhance primary outcomes of patient-
rated unmet needs and of QOL (Slade et al., 2006). Other subjective secondary outcome 
measures were also not enhanced, but the intervention decreased psychiatric inpatient 
days, showing a net benefit analysis of the intervention as cost-effective (Slade et al., 
2006). Despite the interventions not enhancing primary and subjective secondary 
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outcomes, it was cost-effective and showed that it is feasible to apply a meticulously 
developed method to regular outcome assessment in mental health services (Slade et al., 
2006).  
The study’s limitations consisted of the service use data acquired by patients’ self-
report which could have been unreliable (Slade et al., 2006). Another limitation of the 
study was that neither patients nor staff were disguised to allocation status (Slade et al., 
2006). Researchers who conducted the follow-up interviews were partially masked and 
conjectured allocation status accurately for 38% of staff and for 68% of patients (Slade et 
al., 2006). Furthermore, within the control group, 46 (78%) of the 59 patients had a 
member of their staff who also received an intervention-group patient, suggesting that 
contamination was likely among the two groups (Slade et al., 2006). Lastly, the follow-up 
period of 7 months may have been inadequate because more time was needed to capture 
all the possible changes the interventions generated (Slade et al., 2006). When 
considering the evidence by Slade et al. (2006), reviewers should be advised that the 
focus was not on a specific tool to measure mental health outcomes but stressed the 
feasibility of the implementation of a carefully developed technique to routinely evaluate 
outcomes in mental health services.  
Kilbourne et al. (2018) offered numerous recommendations for enhancing the 
quality of mental health care. As part of their recommendations, Kilbourne et al. 
suggested the routine measurement of mental health outcomes and incorporating this 
evaluation within the whole culture of the treatment setting and health care system. 
Primary care setting is considered one of the environments that adoption of mental health 
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outcome measures can be used routinely to improve the quality of mental health services. 
The evidence by Kilbourne et al. added quality to the CPG because they highlighted a 
recommendation on the frequency of mental health outcome measurements. The 
limitation on using this evidence was that the authors discussed the use of the 
recommendations for the general mental health care sectors and not specifically patients 
with anxiety and/or depression in the primary care setting.  
Oliveira, Carvalho, and Esteves (2016) examined the psychometric properties of 
the WHOQOL-BREF by analyzing its construct validity, predictive validity, and 
reliability in a psychiatric sample. The results of the study added to a growing body of 
research findings and provided support for the use of the WHOQOL-BREF for patients 
with mental health conditions in both the inpatient and outpatient settings (Oliveira et al., 
2016). The broad body of research methodically developed with the WHOQOL-BREF, 
reinforces the use of this questionnaire as a reliable and valid instrument to address QOL 
(Oliveira et al., 2016). This study provided a confirmatory evidence of the 
appropriateness of the WHOQOL-BREF with psychiatric inpatients and outpatients 
(Oliveira et al., 2016).  
Despite the strengths, there were limitations in this study. Some of the study 
participants were inpatients in both short-term and long-term residential programs having 
more limited daily activities, which may have affected the results, specifically, regarding 
the environment domain of the WHOQOL-BREF (Oliveira et al., 2016). Additionally, 
because the study used a cross-sectional approach, findings should be required to be 
repeated applying a longitudinal research design to strengthen understanding the 
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dimensionality of the WHOQOL-BREF in psychiatric samples as well as the analytical 
capacity of its domains (Oliveira et al., 2016). The results of the study provided 
implications and guidance for future research and clinical practice (Oliveira et al., 2016). 
The results offered evidence to thoroughly examine the dimensional structure of the 
WHOQOL-BREF across various subgroups, requiring more transparency on the 
WHOQOL-BREF performance in psychiatric samples (Oliveira et al., 2016).  
This study had importance because it was not restricted to participants with a 
specific psychiatric diagnosis or partaking in a particular treatment milieu, emphasizing 
that evaluating the QOL of individuals with mental health disorders receiving care for 
different settings such as inpatient and outpatient facilities must be the core of research 
and treatment goal (Oliveira et al., 2016). Furthermore, because enhancing these 
individuals’ QOL has become a vital outcome measure concerning mental health services 
evaluation, this may add to more understanding that the QOL of those attending various 
psychiatric treatment modalities (such as hospital-based inpatient long-term and short-
term care, ambulatory services, or community-based facilities) could monitor possible 
changes on the individuals’ QOL (Oliveira et al., 2016). 
Tüzün, Aycan, and İlhan (2015) examined the effect of chronic disease on the 
QOL and how QOL changed with comorbidity and socioeconomic status in individuals 
who received care in the primary health care centers using the WHOQOL-BREF. The 
results revealed that people with mental health disorders and diabetes-hypertension 
comorbidity had the most negative impact on their QOL (Tüzün et al., 2015). Mental 
disorders had the worst impact on the psychological and social relationships domains of 
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the WHOQOL-BREF; depression and anxiety were recorded as the diseases with the 
highest negative effect on QOL (Tüzün et al., 2015). The results suggested that providing 
mental health services for primary health care patients with a mental disorders and 
patients with physical chronic diseases is vital to increase their QOL (Tüzün et al., 2015).  
Additionally, findings from this study illustrated that efforts to improve the QOL 
of people with chronic disease cannot be successful without considering the social factors 
of health (Tüzün et al., 2015). These findings support the use of WHOQO-BREF to 
determine QOL in patients suffering from depression and/or anxiety in the primary care 
setting. The self-report of the participants on the presence of chronic disease may have 
been a limitation of this study (Tüzün et al., 2015). Nevertheless, it was essential to apply 
an alternative source because the records of chronic diseases that was registered at 
primary health centers were inadequate (Tüzün et al., 2015). The diseases reported were 
categorized according to the International Classification of Diseases codes for evaluations 
(Tüzün et al., 2015). Even though they may be of the similar group, various diseases can 
impact QOL in different ways (Tüzün et al., 2015). Consequently, a comparison based on 
the diagnoses would have been more illuminating for the researchers (Tüzün et al., 2015).  
Dzevlan et al. (2019) investigated possible improvement of QOL in patients with 
depression and/or anxiety disorder who utilized antidepressants in the study, and the 
tolerability of the treatment administered as well as patients’ compliance during the 
study. This was a clinical, multicenter, prospective, cohort study with 682 adult patients 
with depression and/or anxiety disorder (Dzevlan et al., 2019). The Sleep Scale from the 
Medical Outcomes Study (MOS Sleep Scale) was used to evaluate sleep quality and 
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Quality of Life and Satisfaction Questionnaire (Q-LES-Q-SF) were used to assess life 
enjoyment and satisfaction (Dzevlan et al., 2019).  
The results indicated an increase in sleep quality with antidepressant therapy and 
substantial enhancement in enjoyment and life satisfaction in all the three groups of 
patients considered in the study (Dzevlan et al., 2019). These findings indicated that 
improvement in QOL can be seen with antidepressant therapy (Dzevlan et al., 2019). The 
results of the study may be limited because of the type of questionnaire utilized as a QOL 
measurement (Dzevlan et al., 2019). Dzevlan et al. (2019) mentioned that all the 
questionnaires were self-disclosures with a possible risk of misrepresentation or bias in 
the responses (Dzevlan et al., 2019). The clinician-reported outcome assessments could 
provide a better understanding into patients’ antidepressant therapy related QOL 
(Dzevlan et al., 2019).  
Another limitation was that researchers did not examine how engaged patients 
were in treatment decisions or in the patient–physician relationship, that could further 
clarify the results of patients’ compliance to therapy or treatment satisfaction (Dzevlan et 
al., 2019). A limitation to bear in mind when considering this evidence is that a different 
QOL measurement besides the WHOQOL-BREF was used to assess QOL perceptions. 
Additionally, this evidence was used to provide an overview of specific timeframes of 
when QOL measurements can be done in the clinical setting after starting antidepressant 
therapy for depression and/or anxiety disorders.  
Deane and Fain (2016) examined Peplau’s interpersonal relations theory as a 
framework to help nursing students to comprehend holistic communication skills during 
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their interactions with older adults. Application of Peplau’s theory could be utilized as a 
framework in nursing education to structure classrooms, post-conferences, and skills 
laboratory presentations on components of delivering holistic care and communication 
(Deane & Fain, 2016). Though this evidence was geared towards nursing education, it 
provided valuable information on ways to promote therapeutic nurse-patient relationship 
using Peplau’s theory.  
This evidence supported the interventions (i.e., behaviors and attitudes) that 
clinicians need to demonstrate when asking patients questions on the WHOQOL-BREF 
questionnaire to build effective clinician-patient relationship. When considering the CPG, 
be advised that though Peplau’s interpersonal relations theory has been widely used in 
patients with mental health disorders, a recent evidence discussing the application of the 
three phases of the theory (orientation, working and termination) in patients with 
depression and/or anxiety in the primary care setting, specifically, could not be found.  
The literatures with applicability were graded using the GRADE methodology to 
evaluate its strength and quality to support the recommendations within the guideline. 
The GRADE methodology applies a cohesive and organized approach to determine the 
strength and direction of recommendations (Cabrera & Pardo, 2019). The strength of 
each piece of evidence was assigned a grading level of very low, low, moderate, and 
high. Each piece of evidence was synthesized into an evidence table to manage the 
evidence (Appendix A). The guideline was created using the graded evidence to support 
the recommendations. Recommendations made under each heading of the CPG has its 
corresponding evidence to support them.  
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Once the evidences were graded and analyzed, the guideline was developed. 
Recommendations were written with support from the evidence to illustrate relevance 
and transparency. I used the AGREE II instrument to assess quality and ensured all 
domains of the tool were addressed in the guideline. Afterwards, four experts who 
consisted of an Internal Medicine Primary Care Physician, a Primary Care Clinical 
Psychologist, a Doctor of Public Health and a DNP who still works as a part-time floor 
nurse and a fulltime educator reviewed and evaluated the completed guideline using the 
AGREE II instrument. The guideline and the AGREE II instrument were provided in an 
electronic form to each of the four experts. The AGREE II instrument consist of a 23-
section appraisal evaluating six key aspects of a CPG development (AGREE, 2017). The 
six domains of the tool focused on scope, stakeholder involvement, consistency, clarity, 
applicability, and editorial independence (AGREE, 2017). Experts could rate each 
domain with a score of one to seven with a seven being the maximum attainable score. 
The experts scored each recommendation using the AGREE II tool. In the first 
evaluation of the CPG by the expert panel there was not 100% agreement in terms of the 
scores. The Doctor of Public Health and the DNP gave the guideline a score of seven out 
of seven and graded “yes” for the overall guideline recommendation for use in practice. 
The Primary Care Clinical Psychologist and the Primary Care Physician graded the 
guideline six out of seven and marked it as “yes with modifications” for the overall 
guideline recommendation for use in practice. The results of the first expert review are 





AGREE II Experts Overall Guideline Assessment Scores 
 
Question 1: Rate the overall quality of this guideline. 
 
Question 2: I will recommend this guideline for use 
(Yes/No). 
     
                Rate Yes/No Total Score  
Appraiser 1 7 Yes 7 100% 
 Appraiser 2 7 Yes 7 100% 
Appraiser 3 6 Yes, with 
Modifications 
6 85% 
Appraiser 4 6 Yes, with 
Modifications 
6 85% 
 Total      26        26    92% 
Note. Scoring the AGREE II ranges from 1 (lowest possible quality) through 7 (highest possible quality). 
Since there were four appraisers, the maximum total score achievable was 28 and the minimum total score 
possible was four. The total score percentage was achieved by combining each appraiser’s score and 
dividing by the total possible points. Such as 26/28=.92; .92 x 100 = 92%  
 
The revisions required as suggested by the two experts (primary care clinical 
psychologist and the primary care physician) were to clarify the views and preferences of 
target population; the health benefits, side effects, risks for formulating the 
recommendations; and making the recommendations more specific. Once feedback was 
received from the expert panel, I revised the guideline focusing on the areas suggested by 
the two experts (primary care clinical psychologist and the primary care physician). After 
the revisions were made, I sent it back in an electronic form to the two experts for a 
second evaluation which resulted in a maximum score of seven without the need for 
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additional revisions. The results of the second expert review are presented in Table 2. 
Once there was no revision required from the experts, the CPG was completed (Appendix 
B).   
Table 2 
AGREE II Experts Overall Guideline Assessment Scores 
Question 1: Rate the overall quality of this guideline. 
 
Question 2: I will recommend this guideline for use 
(Yes/No). 
     
                Rate Yes/No Total Score  
Appraiser 3 7 Yes 7 100% 
Appraiser 4 7 Yes 7 100% 
 Total      14  14  100% 
Note. Scoring the AGREE II ranges from 1 (lowest possible quality) through 7 (highest possible quality). 
Since there were two appraisers, the maximum total score achievable was 14 and the minimum total score 
possible was two. The total score percentage was achieved by combining each appraiser’s score and 
dividing by the total possible points. Such as 14/14=1; 1 x 100 = 100%  
 
Recommendations 
The IOM defined clinical guidelines as statements that consist of 
recommendations aimed to enhance patient care and informed by systematic review of 
research as well as assessment of both the benefits and risks of other alternative care 
(Kredo et al., 2016). The IOM statements regarding CPG aligns with the objectives of 
this CPG. This section describes the recommendations on the best way to measure QOL 
in patients with anxiety and/or depression. Various aspects of the recommendations such 
as a discussion of the WHOQOL-BREF tool, domains of the WHOQOL-BREF, 
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reliability of the WHOQOL-BREF, scoring the WHOQOL-BREF and application of 
Peplau’s theory when using the WHOQOL-BREF tool are considered in this section.  
The importance of using the guideline is to help clinicians evaluate QOL in 
individuals with anxiety and/or depression to adjust or enhance their treatment plans for 
better outcomes. After review of the literature, the best tool recommended to use in the 
guideline was the WHOQOL-BREF questionnaire to measure QOL. With the developed 
CPG, a vital aspect is understanding what, when, how to use the WHOQOL-BREF tool 
along with interventions guided by Peplau’s theory to measure QOL. These important 
aspects of the WHOQOL-BREF questionnaire are presented in this section.  
World Health Organization Quality of Life Instrument-Short Form Tool 
The CPG outlines step by step process for measuring QOL in patients with 
anxiety and/or depression disorders. To elicit this measurement, clinicians can follow the 
CPG and inquire from patients the impact of their anxiety and/or depression on their 
QOL in various domains of life. Patients’ QOL can then be evaluated using the 
WHOQOL-BREF questionnaire which consists of different domains such as physical 
health, psychological health, social relationships, and environment. The WHOQOL-
BREF is available in 19 various language versions (WHO, 1996). The WHOQOL-BREF 
questionnaire contains questions relating to each domain of QOL (Feder et al., 2015). The 
domains identified in the WHOQOL-BREF will be the areas of QOL that clinicians can 
use to gather information from patients to appropriately plan their care. The WHOQOL-
BREF questionnaire was derived from the WHOQOL-100 which was also developed by 
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the WHO. The expected outcome of the CPG is the promotion of efficient use of the CPG 
to improve patient care. 
Each domain on the WHOQOL-BREF has specific targeted questions that 
clinicians would ask patients to obtain responses regarding their QOL. The application of 
WHOQOL-BREF questionnaire added quality and strength to the CPG because it is a 
reliable tool and has been used previously in several research to measure QOL. Oliveira, 
Carvalho and Esteves (2016) mentioned that the WHOQOL-BREF was considered a 
valid and reliable instrument for academic research, clinical evaluations, and cross-
cultural comparisons.  
The WHOQOL-BREF has been extensively field-tested in numerous countries 
and its psychometric properties have proven to be sufficient for its utilization in various 
cultures and with a range of population groups such as young people, adults and the 
elderly (Oliveira, Carvalho & Esteves, 2016). It has also been utilized in groups with 
certain medical problems including patients with cancer, epilepsy, and mental disorders 
such as depression, bipolar disorders, psychosis, schizophrenia, and alcohol abuse 
(Oliveira et al., 2016). In a study conducted by González-Blanch et al. (2018), the 
WHOQOL-BREF was used to assess four different QOL domains (physical health, 
psychological health, social relationships, and environment) in primary care patients with 
emotional disorders such as depression, anxiety and somatization. The use of the 
WHOQOL-BREF in this study proved to be valid, reliable, and helped researchers 
understand the relationships between common emotional disorders (such as anxiety 
and/or depression) and the impact on their QOL.  
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The CPG recommended that clinicians administer the WHOQOL-BREF 
questionnaire with each adult patient (ages 18years and older) diagnosed with anxiety 
and/or depression to obtain a baseline assessment score. Thereafter, periodic assessment 
measurement using the WHOQOL-BREF is recommended to evaluate changes in their 
QOL and to modify treatment plans accordingly. Patients who are competent are 
appropriate to self-administer the WHOQOL-BREF after clinicians gives them 
instructions (WHO, 1996). However, an interviewer-assisted or interview-administered 
forms should be read out to patients in cases where the assessment is interviewer-
administered (WHO, 1996).  
Domains of WHOQOL-BREF. When determining the influence of anxiety 
and/or depression on patient’s QOL, series of questionnaires focusing on each domain of 
the WHOQOL-BREF are elicited to gather information for clinicians to make effective 
clinical decisions. The WHOQOL-BREF questionnaire starts with two questions to 
evaluate the patients’ overall QOL and their general health. The questions must appear in 
the order in which they occur as illustrated below under “The WHOQOL-BREF 
Questionnaire” (Appendix C and D).  
The domain on physical health contains questions pertaining to the following 
areas of the patient’s physical health; activities of daily living, dependence on medicinal 
substances and medical aids, energy and fatigue, mobility, pain and discomfort, sleep and 
rest, and work capacity (WHO, 1996). Subsequently, in the psychosocial domain, 
questions regarding the following are asked; bodily image and appearance, negative 
feelings, positive feelings, self-esteem, spirituality/religion/personal beliefs, thinking, 
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learning, memory, and concentration (WHO, 1996). Questions pertaining to social 
relationships are focused on areas such as personal relationships, social support, and 
sexual activity (WHO, 1996). Lastly, questions centered on the person’s environment 
explores financial resources, freedom, physical safety and security, health and social care 
such as accessibility and quality, home environment, opportunities for acquiring new 
information and skills, participation in and opportunities for recreation/leisure activities, 
physical environment (pollution/noise/traffic/climate), and transport (WHO, 1996). 
Reliability of WHOQOL-BREF tool. The WHOQOL-BREF assessment tool 
was published in 1996 by the WHO with the identified instructions as previously stated 
and has been used in its original form without changes since then. It has been widely used 
in numerous research and has been found to be a valid and reliable tool to measure QOL. 
The four QOL domain scores indicate an individual’s perception of QOL in each domain 
(WHO, 1996). QOL domain scores are scaled in a positive direction, for instance, a 
higher score represents a higher QOL (WHO, 1996). The WHOQOL-BREF assessment 
can help clinicians to make judgments regarding the domains in which a patient is mostly 
affected by their disease to make treatment decisions (WHO, 1996). Along with other 
clinical measures, the WHOQOL-BREF will assist clinicians to assess changes in QOL 
over the course of patients’ treatments (WHO, 1996).  
The reliability of WHOQOL-BREF was examined in a literature review of a study 
that observed its psychometric properties by also exploring its construct validity, as well 
as predictive validity in a psychiatric study sample such as those with anxiety and/or 
depression (Oliveira et al., 2016). Findings from this review supported the 
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multidimensionality of the WHOQOL-BREF and demonstrated it to be suitable for 
assessing QOL in psychiatric inpatients and outpatients (Oliveira et al., 2016). 
Additionally, the WHOQOL-BREF showed that it was a valuable instrument to be 
incorporated as part of the routine clinical evaluation, monitoring and an important 
indicator of treatment outcome as well as research (Oliveira et al., 2016). 
When clinicians are administering the WHOQOL-BREF questionnaire, they 
would ask patients about their QOL by asking specific questions under each domain of 
the WHOQOL-BREF questionnaire. For interview-assisted assessment, clinicians can 
read out each question to patients, alongside the response options (WHO, 1996). 
Clinicians would ask patients to choose the most appropriate answer after reading the 
responses (WHO, 1996). Clinicians should inform patients that if they are unsure about 
which response to provide for a specific question, the first response they think of is 
frequently the best one (WHO, 1996). Clinicians should also remind patients of their 
standards, hopes, pleasures and concerns and ask them to think about their life in the past 
four weeks (WHO, 1996). 
Scoring the WHOQOL-BREF. The WHOQOL-BREF questionnaire generates a 
QOL profile of the individual taking the assessment (WHO, 1996). It is likely to obtain 
four domain scores (WHO, 1996). Question one and two are examined separately since 
question one asks about the person’s overall QOL and question two asks about overall 
perception of their health (WHO, 1996). The four domain scores represent the person’s 
perception of QOL in each domain (WHO, 1996). Domain scores are scaled in a positive 
direction such as a higher score indicates greater sense of QOL (WHO, 1996). The mean 
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score of items in each domain is utilized to determine the domain score which is then 
multiplied by four to be comparable to the scores obtained on the WHOQOL-100 (WHO, 
1996). Manual calculation of the scores are presented at the end of the questionnaire for 
the interviewee to calculate the raw domain scores which is then transformed to a 4-20 
score (WHO, 1996). 
Application of Peplau’s Theory and the WHOQOL-BREF Tool. An essential 
aspect of the CPG is the ability for clinicians to incorporate significant phases of Peplau's 
interpersonal relations theory to establish effective relationships with patients. By 
incorporating Peplau’s theory, clinicians can engage in therapeutic relationships with 
patients diagnosed with anxiety and/or depressive disorders, which can assist them to 
holistically care for patients as individuals in need of mental health services. 
Additionally, as clinicians go through various phases of Peplau’s theory to build rapport 
with patients, they can use effective communication skills to collect valuable information 
from patients to understand their needs and the effects of their mental health disorders on 
their QOL. Using such approach can reduce their anxiety and provide a conducive 
environment during the clinician-patient interaction to attain a more reliable, unbiased 
responses from patients to better measure their QOL. Application of Peplau’s theory can 
help to establish interpersonal relations skills that clinicians need to effectively interact 
with patients.  
Contribution of the Doctoral Project Team 
The doctoral project team who contributed their expertise to the project included 
an internal medicine physician who works in a primary care clinic and as a hospitalist in a 
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local hospital, a clinical psychologist who works in outpatient primary care setting, a 
doctor of public health who oversees social workers and programs for the aging adults 
with disabilities, with larger population suffering from anxiety and/or depression, and a 
DNP who is an educator as well as a floor nurse in the emergency department. Each of 
the team members had expertise working with patients diagnosed with anxiety and/or 
depression.  
Team members shared their knowledge regarding the health question considered 
for the guideline and provided helpful feedback on various scholarly references with 
relevance to the guideline development. After the completion of the guideline 
development, each team member graded the guideline for its contents, relevance and 
appropriateness using the AGREE II checklist. Though the CPG was not implemented at 
a specific organization to assess its validity, the evaluation process it underwent using the 
AGREE II instrument by the project team added strength and quality to the guideline. 
The overall aim for the doctoral project was to develop a CPG recommending the best 
way to measure QOL in patients with anxiety and/or depression, no actual 
implementation was intended for the guideline. 
Strengths and Limitations of the Project 
When considering the CPG in clinical practice, there are few facilitators and 
barriers that must be addressed. The main strength of the CPG is the use of the 
WHOQOL-BREF questionnaire to measure QOL in patients diagnosed with anxiety 
and/or depression. Prior to developing the CPG, permission was granted from the WHO 
to utilize the WHOQOL-BREF questionnaire. The WHOQOL-BREF questionnaire is 
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evidence-based and has been supported in prior studies to be of a valid and reliable tool 
to measure QOL in various settings, hence, its use in the CPG. Limitations of the CPG 
was centered on the body of evidence used to support the recommendations.  
First, in the study by Oliveira et al. (2016), some of the study participants were 
inpatients in both short-term and long-term residential programs having more limited 
daily activities which may affected the results, specifically, regarding the environment 
domain of the WHOQOL-BREF (Oliveira et al., 2016). Additionally, since the study 
used a cross-sectional approach, findings should be required to be repeated applying a 
longitudinal research design to strengthen understanding the dimensionality of the 
WHOQOL-BREF in psychiatric samples as well as the analytical capacity of its domains 
(Oliveira et al., 2016). Though this evidence supported the effective use of the 
WHOQOL-BREF questionnaire, it did not focus specifically on anxiety and/or 
depression disorders in outpatient setting but variety of psychiatric samples in both 
inpatient and outpatient settings. The broad sample size could be a limitation in this 
literature review.  
Second, in the study by Tüzün et al. (2015) researchers focused on other chronic 
diseases in addition to mental health disorders to assessed QOL using the WHOQOL-
BREF. Depression and anxiety were not particularly the only mental health disorders 
considered in the study. This is a limitation because the results of the QOL assessment 
could have been influenced by other chronic illnesses of the participants.  
Third, in the study by Dzevlan et al. (2016), researchers used the Quality of Life 
and Satisfaction Questionnaire (Q-LES-Q-SF) to assess life enjoyment and satisfaction in 
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patients taking antidepressant therapy (Dzevlan et al., 2019). The use of the Q-LES-QL-
SF could be considered a limitation when considering this evidence to support the CPG 
because a different QOL measurement besides the WHOQOL-BREF was used to assess 
QOL perceptions. However, bear in mind that this evidence was used to provide an 
overview of specific timeframes of when QOL measurements can be done in the clinical 
setting after starting antidepressant therapy for depression and/or anxiety disorders.  
Last, in the evidence by Deane and Fain (2016), it was generally geared toward 
nursing education but offered valuable information to promote therapeutic nurse-patient 
relationship using Peplau’s theory. When considering the CPG, be advised that though 
Peplau’s interpersonal relations theory has been widely used in patients with mental 
health disorders, a recent evidence discussing the application of the three phases of the 
theory (orientation, working and termination) in patients with depression and anxiety in 
the primary care setting, specifically, could not be found. The application of the evidence 
by Deane and Fain (2016) in the CPG provided a framework to support the interventions 
outlined in the CPG that clinicians can employ when delivering the WHOQOL-BREF 
questionnaire to measure QOL in the target population.  
The CPG recommended a specific tool that can be used to measure QOL in 
patients diagnosed with anxiety and/or depression in the primary care setting. It also 
offered recommendations on how and when to utilize the tool (WHOQOL-BREF 
questionnaire) in clinical practice to improve patient outcomes. Implications for applying 
the recommendations have been considered such as providing clinicians with a better 
understanding of patients’ perceptions of QOL in relation to their anxiety and/or 
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depression, and ability for clinicians to measure QOL in order to better manage their 
treatment plans. An expert review of the CPG has been performed to add quality to its 
application in clinical practice to influence care delivery.  
Summary 
High-quality, evidence-informed CPG provides a way to bridge the gap between 
policy, best practice, local contexts, and the choices of patients (Kredo et al., 2016). For 
decades, clinical guidelines have been supported as a vital component of quality medical 
practice (Kredo et al., 2016). The objective of the CPG was to help clinicians make 
informed clinical decisions regarding the proper care of patients with anxiety and/or 
depression to enhance patient care using evidence-based recommendations. Health 
benefits, side effects, and risks were considered in the formulation of the 
recommendations outlined in the CPG. To accomplish this, the body of evidence 
supporting the recommendations of the CPG underwent critical appraisal to ensure 
relevance, transparency, enhanced health benefits and examination of any potential side 
effects or risks. Upon review of the body of evidence supporting this CPG, no side 
effects, or risks were found. The project team served as a n integral part of the guideline 
by offering their expertise and evaluating the completed guideline using the AGREE II 
instrument. Application of the recommendations made in the guideline can positively 
influence care delivery and promote overall optimal mental health outcome in the 
targeted population.  
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Section 5: Dissemination Plan 
Introduction 
After observing that a local primary care clinic lacked QOL measurement for 
patients with anxiety and/or depression, poor outcomes in various domains of their QOL 
became evident that affected their overall health. Based on this observation, it was 
necessary to develop a CPG with recommendations on the best way to measure QOL to 
holistically care for the patients. I conducted a literature review to evaluate the impact of 
anxiety and/or depression on patients’ QOL, which revealed that depression and anxiety 
negatively impact an individual’s QOL.  
Evidence gathered from the literature to support the CPG illustrated that the 
WHOQOL-BREF questionnaire was a reliable and valid tool to evaluate QOL in patients. 
Previous research analyzed for relevance to the CPG found that the use of WHOQOL-
BREF questionnaire in patients with psychiatric disorders such as anxiety and/or 
depression helped to assess their QOL. Upon review of the literature and analyzing the 
results, I developed a CPG recommending the application of the WHOQOL-BREF tool 
as the best method to measure QOL in the target population.  
The target users for the CPG would be suitable in disseminating the project in a 
larger aspect of the nursing profession and healthcare. The target users for the CPG are 
healthcare clinicians working with patients with anxiety and/or depression in the 
outpatient setting (i.e., primary care). These clinicians can use the CPG to assess the 
target populations’ QOL to generate effective treatments ideal to addressing patients’ 
mental health needs. Other intended users such as registered nurses, licensed practical 
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nurses, and nursing assistants caring for individuals with anxiety and/or depression can 
also apply the CPG as part of the data collection process during patient encounters to 
evaluate the impact of their conditions on their QOL. Based on the information gathered 
from the CPG, nurses can collaborate with advanced practice nurses or physicians to 
either initiate or amend specific treatments to address patients’ needs. After the 
publication of the CPG, its dissemination would target healthcare providers including 
advanced practice nurses, nurses, primary care physicians, psychologists, psychiatrists, 
and other mental health personnel caring for patients diagnosed with anxiety and/or 
depression.  
Because the problem was initially identified at a local primary care clinic, once 
the guideline is available for use, healthcare organizations can first introduce it to either 
their medical officer or hierarchy of the organization for review and then disseminate it 
equally to their clinicians to use to guide their clinical practices. There was no 
implementation for the CPG at a specific organization; however, recommendations on the 
best approach to measure QOL in the target population were outlined step-by-step in the 
guideline. Because there was no implementation of the CPG at a selected institution, 
target users can employ the recommendations in their individual practices, settings, or 
organizations to enhance care delivery and attain optimal mental health outcomes.  
Analysis to Self 
The development of the CPG and my overall project compelled me to consider 
my role as a practitioner, scholar, and project manager. My expertise in working with 
patients with anxiety and/or depression revealed the importance of QOL in these patients. 
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My observation of the lack of proper assessment of patients’ QOL in the primary care 
setting inspired me to take a deeper look into the correlation between anxiety and/or 
depression and QOL. Additionally, as a practitioner, I considered how I could evaluate 
this important concept to holistically care for my patients suffering from anxiety and/or 
depression.  
In my role as a practitioner working with patients diagnosed with anxiety and/or 
depression in the primary care setting, I have had ample opportunities to assess the 
impact of these two mental health disorders on patients’ QOL. I have treated patients 
with anxiety and/or depression using either psychotherapy or pharmacological approach 
and assessed the impact of these treatments using the standardized PHQ9 and GAD7 
without evaluating in depth their QOL due to lack of a standardized measurement tool. 
However, the completion of the DNP project helped me to identify a reliable tool as the 
best approach to assess QOL.  
The development of the CPG helped me to act and grow as a scholar. The 
findings noted through the literature search process for the project provided in-depth 
insights regarding the health question considered for the project. I was able to apply 
knowledge gained through my education to search and obtain reliable resources to 
influence the development of the guideline. 
Leadership skills gained throughout my nursing career helped me to act as a 
project manager in developing the CPG. I was able to effectively collaborate with my 
project team who helped to review the project and to solicit feedback regarding the 
recommendations made in the CPG. As a project manager, I took a leadership role in 
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ensuring that the objectives of my project were met. I also guided my expert panel by 
explaining how to use the AGREE II instrument to review the guideline. This project 
experience significantly enhanced my leadership skills as a practitioner and provided me 
experience as a scholar and project manager. These essential skills will assist me as a 
clinician and help me to meet my professional goals in the future.  
Successful completion of this project was possible due to the support obtained 
from the project team, family, and close friends. Considering that this was my biggest 
educational achievement, I was anxious about potential setbacks that could have 
impacted the overall project. Because the expert panel had various backgrounds, I was 
concerned about how to collaborate with them to solicit feedback on the CPG. 
Additionally, the waiting period to receive feedback from the project team was a 
challenge. However, providing constant communication such as sending periodic 
reminders through e-mails, text messages and phone calls was helpful to bridge the gap 
between the expert panel and myself. Additionally, I explained the intent of the guideline 
to give the expert panel an overview of the overall project. Completing this project has 
enhanced my confidence as scholar practitioner and a leader. The skills obtained through 
this project will guide me to meet my professional goals as I embark on becoming a 
change agent in my community and the nursing profession.  
Summary 
The aim of this project was to develop a CPG recommending the best way to 
measure QOL in patients with anxiety and/or depression in the outpatient setting. The 
developed guideline illuminates a step by step approach to measure QOL life using the 
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WHOQOL-BREF tool. As previously stated, the CPG offers healthcare clinicians 
comprehensive information on measuring QOL, which can influence treatment plans to 
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marital status, work 
status, and income 
Hagerty et al. 
(2017) 
To report the results 
of a confirmatory 
factor analysis 
performed to 







data using both the 
Institute of Medicine 
conceptual model and 
Peplau’s middle-
range theory of 
interpersonal 
relations in nursing 
The study was a 
secondary data 















≥18 years of 
age, who had at 
least one 
overnight 
hospital stay and 
received an 
HCAHPS 




48 hours to 6 
weeks after 
hospital 
discharge to a 
random sample 
of adult patients 
with a range of 
health 
conditions 
A two-factor model 
based on Peplau’s 
theory performed 
sufficiently well, 
whereas a three-factor 
model also based on 
Peplau’s theory fit them 
excellently and 
provided an appropriate 
alternative factor 
structure for the data. 
Results support the use 
of Peplau’s theory to 
show nursing’s vast 





Hofmann et al. 
(2017) 
Examine the impact 
of Cognitive-
behavioral therapy 
(CBT) and selective 
serotonin reuptake 
inhibitors (SSRIs) for 
depression on QOL 






1994 to present 
was conducted 
on 20 June 2014 





CBT (24 studies 
examining 








CBT and SSRIs for 
depression were both 
related to moderate 
improvements in QOL, 
but are probably 
caused by various 
mechanisms 




studies on the 
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anxiety, depression 



























Huo et al. 
(2018) 
Assessed the 
reliability of SF-12 
among individuals 
with behavioral or 
serious mental health 




Care program who 
















































for three years 
Study results 
demonstrated good 
reliability of SF-12 to 
evaluate HRQOL in 
individuals with 
behavioral conditions or 
serious mental illness 





Explored the tension 
among the common 
sense meaning of 
QOL and the efforts 
to pin it down as a 





Not applicable Not applicable Increasing awareness to 
measure QOL in 
individuals with mental 
disorders 






improve quality of 














measurement as an 
ultimate tool for 
enhancing quality of 
mental health care 
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Kong et al. 
(2015) 
Study aimed to 





for acute kidney 
injury (AKI) using 
the GRADE system 
Systematic 







Not applicable Use of GRADE 
system to rate 
the quality of 
evidence  
GRADE was revealed 
as a scientific and 
effective method to 








relationships in the 




















It was discovered that 
“therapeutic listening,” 
“responding to patient 
emotions and unmet 
needs”, and “patient 
centeredness” were the 
main characteristics of 




Kredo et al. 
(2016) 
Aimed to provide a 
guide illustrating 
common standards, 
methods and systems 
utilized in current 
international CPG 
activities and the 







Not applicable No specific 
intervention 
applied 
Concluded that CPG 
methods in the next 









validity of the Patient 
Health Questionnaire 
Anxiety-Depression 
Scale (PHQ-ADS) – 
which merged the 
PHQ-9 and GAD-7 
scales – as a 








Data from 896 
patients enrolled 
in 2 primary 
care-based trials 
of chronic pain 
and oncology 
practice  




PHQ-ADS showed high 
internal reliability 
Movsisyan et 
al. (2018).  
Identified and 
examined existing 
systems for rating the 
quality of a body 
of evidence on the 
effectiveness of 





























Researchers found little 
reporting of rigorous 
procedures in the 
development and 
dissemination of 
evidence rating systems 
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collaborative care for 
anxiety disorders in 
primary care adult 
patients compared to 














included with a 








All studies except 
study four reported a 
substantially greater 
impact of the 
collaborative care 
intervention compared 





Prevalence of mental 
illness in the United 
States 
Statistic data 
Grade: Very low 
Not applicable Not applicable Statistical data on 
mental illnesses in 
United States 




properties of the 
WHOQOL-BREF by 




and reliability in a 
Portuguese 
























plus two items 
representing the 
general QOL 
Support for the 
multidimensionality of 
the WHOQOL-BREF 
which showed it to be 
appropriate for the 




revealed as a valuable 
tool to be integrated as 
part of the routine 
clinical evaluation, 
monitoring and an 
essential indicator of 
treatment outcome as 
well as research 




similarities of the 
concepts of comfort, 
well-being, and 






98 results were 
identified but 
only 18 studies 
were included in 
this review. 
Three studies 





being, and 12 
studies the 





(full text) and 
Scielo 
Comfort appears to be 
more associated with 
symptom relief and/or 
decreased imbalances or 
discomfort, inner peace, 
security, and efficient 
communication. The 
concept of well-being is 
reliant on psycho-
spiritual basis, related to 
happiness and an 
“internal energy.” QOL 
seems to be a broader 





Prasad et al. 
(2016) 
Focused on the social 
changes in the 21st 
century and the effect 
this has had and will 
have on mental 






Not applicable Not applicable Concluded that 
advancement in 
technology as part of 
social change can 
improve awareness, 
help-seeking behaviors, 




Sivertsen et al. 
(2015) 
Reviewed the 
literature on the 
relationship between 
depression 







953 studies were 
revealed; 74 
studies were 
included in the 
review; of these, 
52 were cross-
sectional studies 












Found a substantial 
connection between 
severity of depression 
and poorer QOL in 
older persons, and the 
relationship was found 
to be steady over time, 
regardless of which 
assessment instruments 
for QOL were applied. 
Slade et al. 
(2006) 









160 adult mental 
health patients 
and paired staff 
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group (n-101) 

















 Routine use of outcome 
measures did not 
enhance subjective 




Tüzün et al. 
(2015)  
Analyzed the effect 
of chronic disease on 
the quality of life 




in people who attend 
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Use of the 
World Health 
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Mental disorders among 
the disorders with the 
most negative effect on 
the QOL.  












QOL is scored based on 








Depression being a 






Not applicable Not applicable Concludes with 
educating 
ourselves regarding 
depression and support 
those who 
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The incidence of mental health conditions has resulted in high rates of disabilities 
nationally and globally. Approximately 25% of adults living in the United States has 
some degree of mental health disorder (Huo et al., 2018). Patients suffering from mental 
health problems are known to have higher prevalence of other chronic conditions such as 
heart diseases, diabetes, obesity, asthma, epilepsy, as well as cancer (Huo et al., 2018). 
Precisely, anxiety and depression are among the most prevalent types of mental health 
disorders across different ages of the lifespan (Hohls et al., 2019). Research has showed 
that individuals diagnosed with other medical conditions concurrently with a mental 
health disorder have a significantly higher impairment in their QOL (Huo et al., 2018). 
Quality of life refers to the person’s welfare, contentment in life, physical health, 
perceptions of social relationships, financial status, and functioning in their activities of 
daily living and work (Hofmann et al., 2017). QOL is influenced by the person’s beliefs, 
morals, health, and experiences gained in life. Based on the literature review conducted to 
identify the best QOL measurement tool, a standardized QOL measurement tool could 
not be found. From a local context, a gap in practice was observed at a primary care 
organization. Clinicians who worked in this local primary care setting lacked appropriate 
measurement tool to evaluate QOL in patients diagnosed with anxiety and/or depression. 
As a result of this, poor outcomes in various domains of patients’ QOL became evident 
within the patient population.  
In comparison to other mental disorders, patients with depression have reported 
reduced QOL (Choo et al., 2019). Anxiety disorders can also have a negative effect on an 
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individual’s QOL and are associated with major healthcare productivity and financial 
burden (Muntingh et al., 2016). Given that patients with anxiety and depression have a 
higher risk of negative quality of life, it was vital to find out the best approach to measure 
QOL in patients with anxiety and/or depression. 
Objective 
In practice, guidelines are formulated to offer clinicians the evidence and 
knowledge required to provide efficient, high-quality, and safe care to populations with 
certain clinical situations. The objective of this clinical practice guideline was to help 
clinicians measure QOL in patients suffering from anxiety and/or depression to make 
informed decisions regarding their care and enhance outcomes based on evidence-based 
recommendations. The CPG can serve as a guide for clinicians to evaluate patients’ 
perceptions of quality of life based on various domains such as physical health, social 
relationships, psychological health, and environment in order to make necessary 
adjustments in their care to improve outcomes as well as their quality of life. The 
intended health benefit for applying the CPG is improved perception of quality of life in 
patients with anxiety and/or depression seeking care in the outpatient setting.  
Health Question 
The health question that guided the development of the CPG was: 
PFQ: How should QOL be measured in patients with anxiety and/or depression in 




The intended population that the recommendations can be applied are adult 
patients, all genders, ages 18 years and older with anxiety and/or depression seeking care 
in an outpatient setting. 
Stakeholder Involvement 
The clinical practice guideline development incorporated the works of high-
quality evidence and various reliable tools from other professional groups. These tools 
consisted of the WHOQOL-BREF questionnaire, GRADE methodology and the AGREE 
II instrument. Since the CPG aimed at recommending the best way to measure QOL in 
patients with anxiety and/or depression, there were no direct subjective views or 
preferences obtained from the target population. 
Target Users 
The target users for the CPG are healthcare clinicians working in the outpatient 
setting such as primary care. Healthcare clinicians include but not limited to advanced 
practice nurses, nurse practitioners, nurses, physicians, psychologists, psychiatrists, and 
other mental health professionals. These clinicians can utilize the CPG to assess the target 
populations’ QOL to generate effective treatments ideal to addressing patients’ mental 
health needs. 
Recommendations 
The following recommendations have been reviewed by an expert panel and 
graded utilizing the GRADE methodology. The level of evidence used to support each 
recommendation was graded and assigned a rating of very low, low, moderate, or high as 
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indicated on the GRADE methodology. The guideline recommended the application of 
the WHOQOL-BREF tool to answer the health question:  
PFQ: How should QOL be measured in patients with anxiety and/or depression in 
the outpatient setting?  
The domains of the recommendations addressed the following (1) what to use to measure 
QOL (2) when to measure QOL (3) how to use the WHOQOL-BREF questionnaire and 
(4) how to apply Peplau’s theory with the WHOQOL-BREF tool. The evidence 
supporting each recommendation was illustrated at the end of each section of the 
recommendations. The guideline and recommendations were reviewed by an external 
expert panel against the AGREE II instrument for its contents.  
What to Use to Measure QOL. Though numerous studies on QOL have resulted 
in various tools that clinicians can use in practice, the most suitable approach to measure 
QOL is based on individualized care and the patient’s overall condition as well as the 
intended use of the assessment. 
Use the WHOQOL-BREF questionnaire to measure QOL in patients with anxiety 
and/or depression receiving care in the outpatient setting (GRADE score: Low). The 
WHOQOL-BREF questionnaire is a tool used to assess QOL perceptions and must be 
used without modifications. It has been widely used in numerous researches in its original 
form and has been found to be a valid and reliable tool to measure QOL. With the 
WHOQOL-BREF questionnaire, clinicians can obtain baseline scores in an array of 
areas, as well as observing patterns or changes in QOL over the course of interventions 
(WHO, 1996).  
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Evidence supporting recommendation. Based on a literature review of a study 
that tested the psychometric properties of the WHOQOL-BREF by investigating its 
construct validity, predictive validity as well as reliability in a psychiatric study sample, 
findings supported the multidimensionality of the WHOQOL-BREF which showed 
suitable properties for assessing Qol in psychiatric inpatients and outpatients (Oliveira et 
al., 2016). The WHOQOL-BREF showed that it was a valuable instrument to be 
integrated as part of the regular clinical evaluation, monitoring and an essential indicator 
of treatment outcome as well as research (Oliveira et al., 2016).  
When to Measure QOL. The actual time that clinicians would need to evaluate 
QOL depends on other elements such as the time of initial diagnosis, pharmacotherapy 
initiation, and/or referral to psychotherapy as well as during the titration of medication.  
1. Measure QOL routinely (GRADE score: High) 
a. Measure baseline QOL at the following times (GRADE score: Low) 
i. At the time of initial diagnosis (such as Generalized Anxiety 
Disorder Assessment (GAD7) score of four and above or 
Patient Health Questionnaire (PHQ9) score of four and above) 
ii.  Initial prescription of pharmacotherapy 
iii.  Referral to psychotherapy 
2. Obtain subsequent QOL assessments during follow up appointments to 
evaluate patients’ symptoms and response to treatments (GRADE score: 
Low). The WHOQOL-BREF tool guidelines do not suggest specific time to 
repeat QOL assessment, however, it mentions that various time frames can be 
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used and suggests changing the time scale as appropriate (WHO, 1996). 
Timeframes for follow up QOL assessments is based on current evidence 
supporting when clinicians should follow up with patients after the diagnoses 
of anxiety and/or depression and started pharmacotherapy treatment.  
3. Re-evaluate QOL scores routinely such as at the three weeks follow up visit 
after starting new treatments (i.e., antidepressants and/or psychotherapy) and 
respectively while receiving treatment at seven weeks follow up appointment, 
eleven weeks, 24 weeks, and 36 weeks after baseline (GRADE score: High). 
Evidence supporting recommendation. Upon review of the literature, a study by 
Slade, McCrone, Kuipers, Leese, Cahill, Parabiaghi, Priebe, and Thornicroft (2006) 
conducted a randomized control study to assess the efficacy of standardized outcome 
assessment in 160 adult mental health patients and paired staff. The researchers stressed 
the feasibility of the implementation of a carefully developed technique to routinely 
evaluate outcomes in mental health services (Slade et al., 2006). The study demonstrated 
that a meticulously developed and implemented method to regularly collect and use 
outcome information has been shown to decrease admissions and save money in mental 
health patients (Slade et al., 2006).  
Kilbourne et al. (2018) suggested mental health outcomes ought to be evaluated 
more routinely and must become an aspect of the whole culture of the treatment setting as 
well as the health care system. Routine outcome measurements have been associated with 
enhancements in service delivery and low hospital re-admission rates, but intermittent 
outcome measurement lacked to enhance quality (Kilbourne et al., 2018). Furthermore, 
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regular outcome measurement provided back to the clinician and utilized to influence 
treatment decisions with the patient, led to better QOL (Kilbourne et al., 2018).  
Dzevlan et al. (2019) assessed patients’ QOL after starting antidepressants during 
a nine-month period. QOL measurements were assessed at baseline and five additional 
times. The first QOL assessment was performed three weeks after the baseline, the 
second assessment was completed seven weeks after the baseline, the third assessment 
was performed at 11 weeks after the baseline, the fourth assessment was completed at 24 
weeks after the baseline and the fifth assessment was performed at 36 weeks after the 
baseline (Dzevlan et al., 2019). Clinicians using this CPG can mirror these timeframes for 
follow up visits after the initiation of antidepressants to assess QOL by administering the 
WHOQOL-BREF questionnaire.  
How to Use the WHOQOL-BREF Questionnaire. Proper administration of the 
WHOQOL-BREF questionnaire is key to retrieving relevant responses from patients 
(Appendix D).  
1. Provide the self-administered WHOQOL-BREF questionnaire to competent 
patients to complete the assessment (WHO, 1996) (GRADE score: Very low). 
2. Offer an interviewer-assisted format of the WHOQOL-BREF questionnaire to 
patients who are unable to complete the self-administered questionnaire 
(WHO, 1996) (GRADE score: Very low). 
3. Provide clear instructions to patients on the proper way to complete the self-




4. Read the interviewer-assisted questionnaire out aloud to patients (WHO, 
1996) (GRADE score: Very low). 
5. Review responses under each QOL domain with the patient as indicated on 
the WHOQOL-BREF and clarify any misunderstanding or add further details 
accordingly (WHO, 1996) (GRADE score: Very low).  
6. Discard the assessment if greater than 20% of information is lacking from the 
WHOQOL-BREF questionnaire (WHO, 1996) (GRADE score: Very low).  
7. Calculate the mean score of items in each domain, which is utilized to 
establish the domain score and then multiply by four to be comparable to the 
scores obtained on the WHOQOL-100 (WHO, 1996) (GRADE score: Very 
low). 
Evidence supporting recommendations. Tüzün et al. (2015) evaluated the effect 
of chronic disease on QOL and how QOL alters with comorbidity and socioeconomic 
status in individuals seeking care at primary health care centers. The level of QOL was 
established by using the WHOQOL-BREF. The scale was converted to Turkish, and the 
study of reliability and validity were completed (Tüzün et al., 2015). In harmony with the 
directions prepared for the users of WHOQOL-BREF, the researchers calculated raw 
scores for each domain (Tüzün et al., 2015). Results showed that mental disorders (such 
as depression, anxiety, and somatization) were part of the chronic diseases with the most 
negative impact on the QOL. Mental disorders were the only diseases with a huge effect 
across all domains on the WHOQOL-BREF in the linear regression models (Tüzün et al., 
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2015). Specifically, the results also indicated that depression could lead to a decline in 
several QOL scale domains such as the physical domains (Tüzün et al., 2015). 
How to Apply Peplau’s Theory with the WHOQOL-BREF tool. Applying 
Peplau’s theory of Interpersonal Relations in every patient encounter promotes and helps 
to maintain an effective relationship with patients. Clinicians can apply the interventions 
below during their interactions with patients such as when administering the WHOQOL-
BREF questionnaire.  
1. Address patients by their names and maintain privacy and safety during the 
meet and greet phase (GRADE score: Very low). 
2. Show respect and courtesy towards patients to achieve useful information 
about them as individuals (GRADE score: Very low). 
a. Apply this when asking questions on the WHOQOL-BREF and providing 
instructions on the self-administered questionnaire 
3. Establish rapport with patients to enhance the clinician-patient relationship 
(GRADE score: Very low). 
4. Use professional knowledge and holistic attitude to help the patient with their 
health concerns by asking questions and allow sufficient time for responses 
(GRADE score: Very low). This can be accomplished by performing an 
assessment (i.e., WHOQOL-BREF questionnaire) which can be used to 
educate and influence the patient’s treatment plan. 
5. Interact with patients kindly and be mindful of the use of body language and 
gestures (GRADE score: Very low). 
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Evidence supporting interventions. Peplau’s interpersonal relations theory was 
used to support nursing students to comprehend holistic communication skills in their 
encounters with older adults (Deane & Fain, 2016). Peplau’s theory offers nursing a 
valuable set of three interconnecting and oftentimes intersecting working phases for 
nurses’ interaction with patients during the nurse–patient relationship (Deane & Fain, 
2016). In the orientation phase, the nurse greets the patient by addressing them by their 
name and with professional title (Deane & Fain, 2016). As the orientation phase 
continues, the patient persists to inquire and respond to questions with the nurse, hoping 
to feel secure during their interactions (Deane & Fain, 2016).  
The nurse utilizes professional knowledge and skills alongside a holistic attitude 
to assist the patient solve his or her health concerns (Deane & Fain, 2016). Nurses must 
be mindful of their body language and the gestures they demonstrate during nurse–patient 
interaction and strive from maximum verbal and minimal nonverbal communication 
during patient interactions (Deane & Fain, 2016). In the working phase, which is known 
as the assessment period, nurses need to show respect and maintain privacy to promote 
trust, depict a professional and respectful rapport with the patient (Deane & Fain, 2016).  
Procedure Guideline Update 
The clinical practice guideline should be evaluated and revised yearly by an 
organizational review panel utilizing existing high-quality research, and 
recommendations that are evidence-based. Since the WHOQOL-BREF questionnaire was 
the main component of this CPG and has been in its originality since its publication in 
1996, updates to the guideline may not affect the tool. Any future changes that may occur 
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with the WHOQOL-BREF questionnaire would necessitate an update to the clinical 
practice guideline. In cases whereby updates are needed, partial updates could be made 
and the National Institute for Health and Care Excellence (NICE) recommendations on 
partial updates of guidelines can be used as guidance to make the necessary changes.  
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guideline. There was no related conflict of interest to report for the clinical practice 




Appendix C: The WHOQOL-BREF Questionnaire 
Questions Under Each Domain  
Overall quality of life and general health  
How would you rate your quality of life?  
How satisfied are you with your health? 
Domain 1: Physical health 
To what extent do you feel that physical pain prevents you from doing 
what you need to do?  
How much do you need any medical treatment to function in your daily 
life?  
Do you have enough energy for everyday life?  
How well are you able to get around?  
How satisfied are you with your sleep? 
How satisfied are you with your ability to perform your daily living 
activities?  
How satisfied are you with your capacity for work? 
Domain 2: Psychological 
How much do you enjoy life?  
To what extent do you feel your life to be meaningful?  
How well are you able to concentrate?  
Are you able to accept your bodily appearance?  
How satisfied are you with yourself?  
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How often do you have negative feelings such as blue mood, despair, 
anxiety, depression? 
Domain 3: Social relationships 
How satisfied are you with your personal relationships?  
How satisfied are you with your sex life?  
How satisfied are with the support you get from your friends? 
Domain 4: Environment  
How safe do you feel in your daily life?  
How healthy is your physical environment?  
Have you enough money to meet your needs?  
How available to you is the information that you need in your daily-to-day 
life? 
To what extent do you have the opportunity for leisure activities?  
How satisfied are you with the condition of your living place?  
How satisfied are you with your access to health services?  




Appendix D: The WHOQOL-BREF Questionnaire: Response Options 
 
1. How would you rate your quality of life?  
1 Very poor 2  Poor 3  Neither poor nor good 4  Good  5  Very good 
2. How satisfied are you with your health? 
1  Very dissatisfied, 2  Dissatisfied, 3  Neither satisfied nor dissatisfied, 4  
Satisfied, 5  Very satisfied 
The following questions ask about how much you have experienced certain things in the 
last 
four weeks: 
3. To what extent do you feel that physical pain prevents you from doing what 
you need to do? 
5  Not at all , 4  A little,  3  A moderate amount, 2  Very much, 1  An extreme 
amount 
4. How much do you need any medical treatment to function in your daily life? 
5  Not at all , 4  A little, 3  A moderate amount, 2  Very much, 1  An extreme 
amount 
5. How much do you enjoy life?  
1  Not at all , 2  A little, 3  A moderate amount, 4  Very much, 5  An extreme 
amount 
6. To what extent do you feel your life to be meaningful?  
1  Not at all , 2  A little, 3  A moderate amount, 4  Very much , 5  Extremely 
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7. How well are you able to concentrate?  
1  Not at all , 2  A little, 3  A moderate amount, 4  Very much , 5  Extremely 
8.  How safe do you feel in your daily life? 
1 Not at all, 2  A little, 3  A moderate amount, 4  Very much , 5  Extremely 
9.     How healthy is your physical environment? 
1 Not at all, 2  A little, 3  A moderate amount, 4  Very much , 5  Extremely 
The following questions ask about how completely you experience or were able to do 
certain 
things in the last four weeks: 
10. Do you have enough energy for everyday life? 
1  Not at all, 2  A little, 3  Moderately, 4  Mostly, 5  Completely 
11. Are you able to accept your bodily appearance? 
1  Not at all, 2  A little, 3  Moderately, 4  Mostly, 5  Completely 
12. Have you enough money to meet your needs? 
1  Not at all, 2  A little, 3  Moderately, 4  Mostly, 5  Completely 
13. How available to you is the information that you need in your day-to-day life? 
1  Not at all, 2  A little, 3  Moderately, 4  Mostly, 5  Completely 
14. To what extent do you have the opportunity for leisure activities? 
1  Not at all, 2  A little, 3  Moderately, 4  Mostly, 5  Completely 
15. How well are you able to get around? 
1 Very poor, 2  Poor, 3  Neither poor nor good, 4  Good, 5  Very good 
16. How satisfied are you with your sleep? 
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1  Very dissatisfied, 2  Dissatisfied, 3  Neither satisfied nor dissatisfied, 4  
Satisfied, 5  Very satisfied 
17. How satisfied are you with your ability to perform your daily living activities? 
1  Very dissatisfied, 2  Dissatisfied, 3  Neither satisfied nor dissatisfied, 4  
Satisfied, 5  Very satisfied 
18. How satisfied are you with your capacity for work? 
1  Very dissatisfied, 2  Dissatisfied, 3  Neither satisfied nor dissatisfied, 4  
Satisfied, 5  Very satisfied 
19. How satisfied are you with yourself? 
1  Very dissatisfied, 2  Dissatisfied, 3  Neither satisfied nor dissatisfied, 4  
Satisfied, 5  Very satisfied 
20. How satisfied are you with your personal relationships? 
1  Very dissatisfied, 2  Dissatisfied, 3  Neither satisfied nor dissatisfied, 4  
Satisfied, 5  Very satisfied 
21. How satisfied are you with your sex life? 
1  Very dissatisfied, 2  Dissatisfied, 3  Neither satisfied nor dissatisfied, 4  
Satisfied, 5  Very satisfied 
22. How satisfied are you with the support you get from your friends? 
1 Very dissatisfied, 2  Dissatisfied, 3  Neither satisfied nor dissatisfied, 4  
Satisfied, 5  Very satisfied 
23. How satisfied are you with the conditions of your living place? 
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1  Very dissatisfied, 2  Dissatisfied, 3  Neither satisfied nor dissatisfied, 4  
Satisfied, 5  Very satisfied 
24. How satisfied are you with your access to health services? 
1  Very dissatisfied, 2  Dissatisfied, 3  Neither satisfied nor dissatisfied, 4  
Satisfied, 5  Very satisfied  
25. How satisfied are you with your transport? 
1  Very dissatisfied, 2  Dissatisfied, 3  Neither satisfied nor dissatisfied, 4  
Satisfied, 5  Very satisfied 
The following question refers to how often you have felt or experienced certain things in 
the 
last four weeks. 
26. How often do you have negative feelings such as blue mood, despair, anxiety, 
depression? 




Appendix E: World Health Organization Copyright Authorization for WHOQOL-BREF  
(Permission #: 311574) 
Dear Mary, 
Thank you for submitting the online form and for your interest in World Health 
Organization (WHO) Quality of Life materials. On behalf of WHO, we are pleased to 
authorize your request to reproduce, reprint and/or translate WHOQOL tools and 
instruments as detailed in the form below, subject to the terms and conditions of the non-
exclusive license below. WHOQOL-100 and WHOQOL-BREF available language 
versions and the translation guidelines are available for download at: 
http://terrance.who.int/mediacentre/data/WHOQOL/  
For more information and other WHOQOL materials, visit WHOQOL website. We thank 




WHO Permissions Team  
WORLD HEALTH ORGANIZATION 
Non-exclusive licence to use selected WHO published materials 
You submitted a request, through WHO’s online platform, for permission to reprint and 
reproduce certain WHO copyrighted material (the “Licensed Materials”). This is a legal 
agreement (the “Agreement”) between you and WHO, granting you a license to use the 
Licensed Materials subject to the terms and conditions herein. 
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Read this Agreement in its entirety before using the Licensed Materials. 
By using the Licensed Materials, you enter into, and agree to be bound by, this 
Agreement. This license is granted only for original materials belonging to WHO. If any 
part of the WHO published materials you wish to reproduce are credited by WHO to a 
source other than WHO, those materials are not covered by this Agreement and are not 
part of the Licensed Materials. You are responsible for determining if this is the case, and 
if so, you are responsible for obtaining any necessary permission from the source of 
those third-party materials prior to their use. 
If you enter into this Agreement on behalf of an organization, by using the Licensed 
Materials you confirm (represent and warrant) that you are authorized by your 
organization to enter into this Agreement on the organization’s behalf. In such a case, the 
terms “you” and “your” in this Agreement refer to, and this Agreement applies to, the 
organization. 
WHO grants this license to you based on the representations and warranties you made in 
the license request you submitted through WHO’s online platform. If any of those 
representations and/or warranties are or become false or inaccurate, this license 
agreement shall automatically terminate with immediate effect, without prejudice to any 
other remedies which WHO may have.  
If you have questions regarding this Agreement, please contact permissions@who.int 
1. License. Subject to the terms and Conditions of this Agreement, WHO grants to 
you a worldwide, royalty free, non-transferable, non-sublicensable, non-exclusive 
licence to use, reproduce, publish, and display the Licensed Materials in the 
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manner and using the media indicated in the Permissions Request Form you 
submitted to WHO (the “Licensed Use”). This licence is limited to the current 
edition of your work. Future editions or a different use of the Licensed Materials 
will require additional permission from WHO. If your request includes translation 
into different languages, then non-exclusive permission is hereby granted to 
translate the Licensed Materials into the languages indicated in accordance to 
article 4 of this Agreement. 
2. Licensed Use. The Licensed Material shall be used in the manner and using the 
media indicated in the Permissions Request Form you submitted to WHO (the 
“Licensed Use”). The Licensed Materials are intended for use in clinical research, 
drug trials, conducting assessments and studies, for use by clinicians in clinical 
contexts and for any academic and educational use. The Licensed Materials 
should not be sold individually or incorporated into products for sale, without 
written authorization from WHO. 
3. Retained Rights. Copyright in the Licensed Materials remains vested in WHO, 
and WHO retains all rights not specifically granted under this Agreement.  
4. Translation of the Licensed Materials. The Translation shall be faithful to the 
original English text and rendered into good literary and scientific language. The 
Translation should be done in accordance with the translation guidance 
methodology provided by WHO and available for download 
at http://terrance.who.int/mediacentre/data/WHOQOL/WHOQOL-
100/Guidelines/. The PDF of the translation should be provided to WHO with 
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permission 1) to make the PDF available on WHO web site and institutional 
repository and 2) to use, amend, adapt, reproduce, publish and distribute the PDF 
or its part(s) for any purpose whatsoever. 
5. Mandatory Acknowledgement. In every instance of the Licensed Use, you must 
make suitable acknowledgement of WHO as follows, either as a footnote or in a 
reference, as follows. In addition, If the Licensed Materials originate from 
the WHO web site, you must also include the URL reference and the date 
accessed. 
“Reproduced with permission from (TITLE), Geneva, World Health Organization 
(WHO), (Year of publication), (URL, accessed (insert date). WHO does not endorse any 
specific companies, products or services.” 
 Translations and adaptations of the Licensed Materials should be attributed as follows: 
“Translated into (insert language) from (TITLE), Geneva, World Health Organization 
(WHO), (Year of publication), (URL, accessed (insert date). WHO is not responsible for 
the content or accuracy of this translation/adaptation. In the event of any inconsistency 
between the English and the insert language translation, the original English version 
shall be the binding and authentic version.” 
6. Product Delivery: The Licensed Materials can be downloaded online 
at http://terrance.who.int/mediacentre/data/WHOQOL/  
7. Altering or Modifying the Licensed Materials. As part of the Licensed Use, you 
may minimally alter the Licensed Materials to match the format or style of your 
publication. Any other alteration or modification of the Licensed Materials 
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(including abbreviations, additions, or deletions) may be made only with the prior 
written authorization of WHO. You may not add company or product branding to 
the Licensed Materials. 
8. Appropriate and Prohibited Uses. You must use the Licensed Materials in a 
factual and appropriate context. You may not use the Licensed Materials in 
association with any product marketing, promotional, or commercial activities, 
including, without limitation, in advertisements, product brochures, company-
sponsored web sites, annual reports, or other non-educational publications or 
distributions. Any additional use requires written permission from WHO. 
9. No WHO endorsement. You shall not state or imply that WHO endorses or is 
affiliated with your publication or the Licensed Use, or that WHO endorses any 
entity, organization, company, or product. 
10. No use of the WHO logo. In no case shall you use the WHO name or emblem, or 
any abbreviation thereof.  
11. No Warranties by WHO. All reasonable precautions have been taken by WHO to 
verify the information contained in the Licensed Materials. However, WHO 
provides the Licensed Materials to you without warranty of any kind, either 
expressed or implied, and you are entirely responsible for your use of the 
Licensed Materials. In no event shall WHO be liable for damages arising from 
your use of the Licensed Materials.  
12. Your Indemnification of WHO. You agree to indemnify WHO for, and hold 
WHO harmless against, any claim for damages, losses, and/or any costs, 
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including attorneys' fees, arising in any manner whatsoever from your use of the 
Licensed Materials or for your breach of any of the terms of this Agreement. 
13. Termination. The license and the rights granted under this Agreement shall 
terminate automatically upon any breach by you of the terms of this Agreement. 
Further, WHO may terminate this license at any time with immediate effect for 
any reason by written notice to you.  
14. Entire Agreement, Amendment. This Agreement is the entire agreement between 
you and WHO with respect to its subject matter. WHO is not bound by any 
additional terms that may appear in any communication from you. This 
Agreement may only be amended by mutual written agreement of you and WHO. 
15. Headings. Paragraph headings in this Agreement are for reference only. 
16. Dispute resolution. Any dispute relating to the interpretation or application of this 
Agreement shall, unless amicably settled, be subject to conciliation. In the event 
of failure of the latter, the dispute shall be settled by arbitration. The arbitration 
shall be conducted in accordance with the modalities to be agreed upon by the 
parties or, in the absence of agreement, with the rules of arbitration of the 
International Chamber of Commerce. The parties shall accept the arbitral award 
as final. 
17. Privileges and immunities. Nothing in or relating to this Agreement shall be 
deemed a waiver of any of the privileges and immunities enjoyed by WHO under 
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